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Cytotoxic T Lymphocytes (CTLs) secrete a pore-forming cytolysin, perforin,
which permeabilizes target membranes. During interactions with target cells, CTLs
remain undamaged despite exposure of their plasma membranes to secreted perforin. We
have shown that murine tumor cells arrested at the Gi phase of the cell cycle are less
susceptible to perforin than those in G2 and S phases. The study has been extended to
other pore-former proteins: streptolysin-0 (SLO) and melittin. We have foimd that A20
and P815 target cells at the Gi/S interface are less susceptible to SLO-mediated lysis, but
do not differ in susceptibility to melittin. Also, it was observed that the perforin-resistant
CTL line BIID-3 is also resistant to SLO, but, like its tumor targets, is readily lysed by
melittin. These data demonstrate specificity of resistance mechanisms for large pore-
formers such as SLO rather that small membrane-perturbing polypeptides. Membrane
repair processes were monitored by endocytosis ofFITC conjugated dextran via flow
cytometry. P815 and A20 cells arrested at the Gi/S interface manifested enhanced
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endocytosis, implying that endocytic clearance of lesions may explain the decreased
susceptibility of arrested Gi/S cells and may contribute with the resistance ofCTLs.
In addition, it was examined whether perforin resistance ofCTLs is related to
proliferative status and position in the cell cycle. The data indicated that the CTL cell
line BIID-3 at all stages of the cell cycle remains resistant to perforin. The role of lipids,
specifically gangliosides, in CTL protection was exam preliminary; data demonstrated
distinct difference in gangliosides profile.
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1.1 Natural and Adaptive Immunity
The immune response to infectious agents consists of two aspects which may be
distinguished as natural and adaptive immunity. The natural immune response consists
of factors which recognize and interact with attributes broadly shared by infectious
agents. These include common lipids or cell wall components of gram-negative and
gram-positive bacteria. Thus, the membrane permeabeabilizing complement cascade can
be activated by components of bacteria membranes and cell walls. Lysozyme which
digests cell walls of bacteria is present in most body fluid. Cationic peptides elaborated
by insects and also in mammalian white blood cells disrupt bacterial membranes.
Adaptive immunity requires an activation phase specific to a pathogen and reacts to
attributes specific to the given pathogen. This includes the induction of immunoglobulins
and their effector fimction. It also includes antigen-specific responses of T cells. This
adaptive immune response is characterized by high specificity and also by memory.




When the immune system functions optimally, antigen is eliminated before
symptoms develop. Extracellular antigens, including surface components of bacteria and
their toxins, are most accessible to immune elimination. Digestive enzymes, of
lysosomal origin, oxygen radicals, and peroxides released by macrophages and
leukocytes during inflammation kill these pathogens [Abbas, Litchman and Pober,
2000]. Antibodies, also called immunoglobulins (Ig), are produced by B lymphocytes,
and are critical for defense against extracellular pathogens. Subsequently, antibody-
coated, i.e., opsonized, pathogens are recognized by phagocytic cells. They are engulfed
by phagocytic cells and degraded. Alternatively, antibodies binding to the surface of a
pathogen activate proteins of the complement system. Complement proteins bound to the
pathogens also result in opsonization via binding complement receptors on phagocytes.
Other peptides derived from complement serve to recruit phagocytic cells to the site of
infection. The terminal components of the complement, C9, lyses microorganisms and
infected cells by forming pores in their membranes. The effector mechanism that is
recruited in a particular response is determined by the class of the antibodies,
immunoglobulins (Ig), produced.
Immunoglobulins (Ig) are antigen-binding proteins occurring in five isotypic
classes differing in structure: IgM, IgD, IgG, IgA, IgE. Upon activation with antigen, B
cells secrete IgM. Secreted IgM is a pentamer of immunoglobulin dimers resulting in 10
antigen binding sites. IgM binds antigen and complement very efficiently but enters the
tissue slowly due to its size. When B cells are stimulated by helper cytokine signals, they
secrete IgG or IgA with the same antigenic specificity as the previous IgM.
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This is referred to as the class switch. IgG is the predominant antibody isotype in
serum; it has two antigen binding sites and can easily enter the tissue from circulation.
IgG activates complement; also IgG-antigen complexes bind to Fc receptors (FcR) and
facilitate phagocytosis and other cellular reactions. IgA is expressed predominantly in
mucosal lymphoid tissue; and is present in mucous secretions of respiration, digestive,
and urogenital tracts and in breast milk. IgG and IgA binding neutralize viruses and
toxins usually by blocking host binding determinants. The IgE response is important for
control of helminthes, parasitic infections and also mediates allergic reaction. IgE binds
to FcR on mast cells, and provokes the release of histamine. [Decker, J., 2000]. In some
instances particles are too large for phagocytic ingestion. These include helminth and
other parasites. Eosinophils and monocytes can attack the surface membrane and
discharges the contents of their secretory granules. These granules contain cationic
peptides, among other factors, that damage cell membranes. Eosinophils and monocytes
cells also secrete reactive oxygen species, nitric oxide, and hypohalite. While the
principal phagocytes for destruction of bacteria are macrophages and neutrophils,
clearance ofparasites such as helminths depends heavily on eosinophils.
1.3 Cell-mediated Immunity
Cell-mediated immunity involves cytotoxic cells such as T cells, macrophages
and Natural Killer (NK) cells, and provides defense against intracellular pathogens. T
cells can kill infected cells directly with cytotoxic T lymphocytes (CTLs), or
inflammatory T cells. They activate macrophages to kill pathogens in intracellular
vesicles. T helper cells also are important for the activation ofB cell response.
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Other immune cells can exploit the specificity of Ig to recognize and kill targets through
processes referred to as antibody-dependent cell-mediated cytotoxicity (ADCC),
described later in this chapter.
1.3.1 T-Lvmphocvtes
The recognition of target cells by T-lymphocytes is receptor specific and
restricted through the major histocompatibility complex (MHC) [Kagi, et al., 1996;
Lowin, et al., 1995]. CDS T cells, also known as cytotoxic T lymphocytes (CTLs), kill
cells infected by intracellular pathogens and viruses. The T cell receptor (TCR) of CDS
T cells (TCR/CD3) interacts with peptides, derived from the pathogen, that are bound to a
MHC class I molecule on the surface of the target cell. This specific interaction leads to
the release of cytotoxic products in granules by CTLs and lysis of target cells. Activated
CDS cells T cells are able to induce cytolysis of infected cells by two distinct molecular
pathways: the granule exocytosis pathway, dependent on the pore-forming molecule
perforin and granzymes, or by the upregulation of FasL (CD95L), which can initiate
programmed cell death by aggregation of Fas (CD95) on target cells. Both pathways,
activated in response to signals from the TCR, also stimulate the caspase cascade in the
target cell, leading to apoptotic death [Harty JT and et al., 2000].
CD4 T lymphocytes recognize peptide fragments of antigens complexed to MHC
class II molecules. These peptide Segments result from proteolysis of antigens within
endosomes and are transported to the cell surface with MHC molecules. CD4 T cells
secrete a host of cytokines and lymphokines. Cytokines are soluble growth factors that
affect T cells, B cells and many other cell types. CD4 T cells are classified by the range
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of cytokines they produce. Thl cells secrete IL-2 (Interleukin 2) and IFN-y (Interferon,
IFN) but not IL-4 or IL-5. Cytokines produced by CD4 Thl cells principally activate
other T cells, NK cells, and macrophages. Upon activation, inflammatory CD4 T cells
(Thl), activate macrophages, allowing them to destroy intracellular pathogens efficiently
causing an inflammatory response.
In contrast, Th2 CD4 T helper cells secrete IL-4 and IL-5, but not IL-2 or IFN-y.
Cytokines produced by Th2 cells mostly affect B cells. Interaction between molecules on
the surface of the CD4 T cell and B cell results in mutual activation and cytokines
secretion by Th2 cells. Cytokines stimulates the activation of B cells to differentiate and
secrete antibodies [Benjamini, E., Sunshine, G., and Leskowitz, S., 1996].
1.3.2 Macrophages
Macrophages are large mononuclear phagocytic cells important for innate
immunity. They are migratory cells derived from bone marrow precursors and are found
in most tissues of the body. Macrophages become cytotoxic when activated by cytokines
such as IFN-y produced by CD4 T cells (Thl) and bacterial products such as
lipopolysaccharide. These activated macrophages are cytotoxic to cells infected with
pathogens or tumor cells. The damaging and killing activity of activated macrophages is
due to products that they release, notably cationic peptides and tumor necrosis factor-a
(TNF-a) and reactive oxygen species. CD4 Thl cells activate macrophages by contact-
mediated signals delivered through CD40L-CD40 interactions and by the cytokine IFN-y.
In response to CD40 signals and IFN-y, production of several important proteins in
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macrophages is increased. Activated macrophages kill phagocytosed and extracellular
microbes, mainly by producing microbicidal reactive oxygen intermediates, nitric oxide
(NO), and cationic peptides. Macrophage activation leads to increased synthesis of an
enzyme called phagocyte oxidase, which catalyzes the generation of reactive oxygen
intermediates, and also of inducible NO synthase, which synthesizes NO. Reactive
oxygen intermediates and NO are potent microbicidal agents that are produced within
macrophages and able to kill ingested microbes. NO causes disruption of mitochondrial
iron/sulfur protein leading loss of oxidative phosphorylation. Activated macrophages
contain increased amounts of lysosomal enzymes, which destroy phagocytosed microbes
after fusion of phagosomes with lysosomes. Reactive oxygen intermediates, NO, and
lysosomal enzymes may also be released into adjacent tissue, where they kill
extracellular microbes and may cause damage to normal tissue causing inflammation.
Activated macrophages stimulate acute inflammation through secretion of
cytokines, mainly TNF, IL-1 and chemokines, and short-lived lipid mediators such as
platelet-activating factor, prostaglandins and leukotrienes. The collective action of these
macrophage-derive cytokines and lipid mediators is to produce a local inflammation rich
in neutrophils, which also destroy infectious organisms. Also activated macrophages
(and neutrophils) remove dead tissues to facilitate repair after the infection is controlled
[Abbas, Litchman and Pober, 2000].
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1.3.3 Natural Killer cells fNKl
NK cells are lymphoid cells foimd in spleen, lymph nodes, bone marrow and
peripheral blood. These cells can lyse a variety of target cells, such as virally infected
cells and cells from a number of different tumors. The mechanism ofNK cell-mediated
cytolysis is essentially the same as that of cytolysis by CTLs. NK cells, like CTLs, have
granules that contain a protein called perforin, which creates pores in target cell
membranes, and enzymes called granzymes, which enter through perforin pores and
induce apoptosis of target cells. By killing virus infected cells, NK cells eliminate the
reservoir for the infection. The granules ofNK cells, like those ofCTLs, also contain an
antibiotic peptide called granulysin, which can enter infected cells through perforin pores
and directly kill intracellular microbes [Hanson, D.A., and Krensky, A.M., 2000]. Some
tumors, especially those of hematopoietic origin, are targets ofNK cells, perhaps because
they do not express normal levels of class IMHC molecules.
NK cells lyse virally infected cells before antigen-specific CTLs can become fully
active, that is, during the first few days after viral infection. NK cells are expanded and
activated by cytokines of innate immunity, such as IL-12 and IL-15, and they kill infected
cell, especially those that display reduced levels of class I molecules. As with Thl cell,
the IFN-y secreted by NK cells activates macrophages to destroy phagocytosed microbes.
This IFN-y-dependent NK cell-macrophage reaction can control intracellular bacteria
infections, such as Listeria monocytogenes for several weeks and thus allow time for T
cell-mediated immunity to develop and eradicate the infection. Depletion of NK cells
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leads to increased susceptibility to infection by some viruses and intracellular bacteria
[Abbas, Litchman, and Pober 2000].
Natural killer (NK) cells express a superfamily of surface proteins that share
common structural features: dimeric type II integral membrane protein with extracellular
domains resembling C-type lectins. These receptors are encoded by a single genetic
region called the NK complex. The NK complex include several families of genes
including NKR-PI, ly-49, CD94/NKG2, and NKG2D. Different NK complex encoded
receptors have been shovra to activate or to inhibit NK-cell function, and different
receptors within the same family can have opposing functions, i.e,. stimulatory or
inhibitory [Ryan, J.C., et al., 2001].
1.3.4 Antibody-Dependent Cell-mediated Cytotoxicity (ADCCf
Surveillance of cell surfaces for foreign peptides, associated with intracellular
infections, is largely the province of cellular immune responses mediated by effector T
cells. However, antibodies can be produced against viral proteins expressed on the
surface of infected cells, and cells bound by such antibodies can be killed by NK cells.
The destruction of antibody-coated target cells by NK cells results from antibody-
dependent cell-mediated cytotoxicity (ADCC) and is triggered when antibody bound to
the surface of a cell interacts with Fc receptors on the natural killer cell. NK cells express
the Fc receptor FcyRIII (CD16). FcyRIII recognizes the IgGl and IgG3 subclasses and
triggers cytotoxic attack by the NK cell on antibody-coated target cells by mechanisms
exactly analogous to those we have seen in CTLs, involving the release of cytoplasmic
granules containing perforin and granzymes. Another class of cytotoxic cells expressing
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Fc receptor are macrophage. The importance ofADCC in defense against infection with
bacteria or viruses has not yet been fully established. However, ADCC does represent
another mechanism by which an effector cell lacking specificity for antigen could
mediate antigen-specific fimctions by recognizing the antibody molecules engaged
through an Fc receptor.
1.4 Mechanism ofCDS T-cell-mediated cytotoxicity
Cytotoxic T lymphocytes (CTLs) kill target cells via two pathways. Both
pathways are initiated by TCR interaction with the antigen in the target cells MHC. TCR
signaling induces cytoplasmic polarization, resulting in the secretory apparatus being
oriented to face the bound target cell. The two cytotoxic pathways share some immediate
signaling steps after antigen recognition and then diverge. The granule exocytosis
pathway results in rapid release of the preformed proteins perforin and granzymes,
initially bound to proteglycan, into the synaptic space between effector and target cell.
The electrostatic complex of proteoglycan, perforin and granzymes dissolves, allowing
perforin to undergo a calcium-induced conformational change and to insert in the target
cell plasma membrane, oligomerize, and forms polyperforin pores [Pasternack, et al.,
1986; Mason, et al., 1986; Henkart, P.A., 2000]. Polyperforin inserted into the target
cell’s membrane causes rapid and sustained membrane depolarization. At high doses of
perforin, cells do not recover their membrane depolarization and die by necrotic cell lysis
due to the membrane damage caused by perforin. [Podack, E.R., 1986; Henkart, et al.,
1984; Kagi, et al., 1994a; Podack, E.R., 2000]. At lower perforin doses, cells may
survive a necrotic lysis, through active membrane repair via endocytosis. Still granzymes
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may enter the target cell directly through the perforin pore or subsequent to endocytosis
and endosome disruption. Once free in the cytoplasm, granzymes trigger both caspases-
dependent and caspases-independent damage pathways, killing the target cell by
apoptosis (Figure 1.1).
The FasL/Fas pathway is also initiated by the TCR activation. It results in FasL
mRNA expression and de novo synthesis of the trimeric FasL membrane protein in the
endoplasmic reticulum. This protein is processed by the Golgi apparatus, after which it is
directed either directly to the plasma membrane via vesicles or to the granules where it
can be released via a subsequent TCR stimulus [Henkart, P.A., 2000]. Then the FasL
crosslink Fas receptor on the target cell. And this interaction initiates the activation of a
signal transduction cascade, via FADD and involving caspase-8, which is part of the
caspases family (Figure 1.1). Caspases are family of enzymes that regulates all the
morphological changes associated with apoptotic death, including the fragmentation of
chromosomal DNA. [Kagi, et al., 1994a; Lowin, et al., 1994; Kagi, et al., 1994b;
Henkart, P.A., 2000]. All target damage in the FasL/Fas pathway is blocked by caspase
inhibitors [Henkart, P.A., 2000]
This CTL lethal hit is delivered within 10-15 minutes ofT cell-target cell contact
[Henkart, P.A., 1995; Podack, E.R., 1986], and the T cell can then detach from the
surface of the target cell and go on to find other potential targets, without being killed
themselves in the process.
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Figure 1.1 CTL Cytotoxic Mechanisms.
CTLs use two pathways to kill targets cells. The granule exocytosis pathway (solid
arrows) results in rapid release of perforin and granzymes (P, G) into the synaptic space
between CTL and target cell. The FasL/Fas pathway (dashed arrows) depends on the
interaction of surface FasL with Fas on the target cell, thereby triggering caspase
activation via FADD (see text 1.4) [Henkart, P.A., 2000].
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1.5 The Granule Secretory Pathway
CTLs kill cells infected by microorganisms, such as viruses and in some cases
intracellular bacteria. The killing of the infected cells is due in part to the release of
cytotoxic products contained in granules inside the CTLs and the induction of apoptosis
or cell death in the infected cell through other components in the T cell. These secretory
granules contain a pore-forming protein referred to as perforin or cytolysin, granzymes of
the serine hydrolases family, chemokines and proteins such as serglycin-proteoglycans,
CTLA-4, granulysin and FasL
1.5.1 Components of the Cytotoxic Granules
Granules are storage organelles for the secretory products released by Ca-
dependent stimulus through the TCR. Cytotoxic granules of activated CTLs are
synthesized de novo, when the cells receive signals to proliferate. The genes of perforin,
granzymes A, granzymes B, and other granzymes are activated, and within 24-48 hours
the synthesized proteins are appropriately routed and assembled into functional granules.
After synthesis of the granzymes important posttranslational modifications occur.
First, the granzymes must be processed to assume an active conformation. The
signal peptide is first removed by a signal peptidase, and then a short prosequence is
removed by a second enzyme. In the case of granzymes A and B, the second enzyme is
clearly dipeptidyl-peptidase I (DPPI) [Pham and Ley, 1999; Russell and Ley, 2002].
Most granzymes are also glycosylated and use the lysosomal-endosomal sorting
system dependent on maimose-6-phosphate receptor pathway, in the golgi apparatus.
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Modification of the granzymes appears to be important for their entry into target cells
[Podack, E.R., 2000; Russell and Ley, 2002].
Perforin does not use this targeting system and is glycosylated with complex
carbohydrates when leaving the trans-golgi. The targeting signals for perforin to traffic
to granules have not been identified. Post-translational proteolytic processing of
intracellular perforin was observed by Griffith’s group [Uellener, et al., 1997]. Their
results demonstrated that perforin is synthesized as a 70-kDa precursor and is cleaved at
the carboxy terminus to yield the activated 60-kDa form. The enzyme that mediates this
cleavage has not yet been identified but it may require an acidic environment. Besides
perforin and granzymes, granules contain an insoluble core of serglycin-Proteoglycans.
This core is an electrostatic complex of cationic proteins with chondroitin sulfate-
containing proteoglycans covalently linked to the ser-gly repeat domain of the small
protein termed serglycin. This molecule is thought to act as a scaffold for packing
perforin and granzymes, and given its anionic nature apparently binds the highly cationic
perforin and granzymes. After secretion, the proteoglycan-protein core complex initially
persists but then dissolves, presumably due to the change in pH and ionic environment
[Henkart, P.A., 2000; Russell and Ley, 2002]. Because proteoglycan binding to perforin
inhibits its cytolytic activity, it may play a role in effector cell self-protection after
degranulation. But more evidence is needed to support this hypothesis [Henkart, P.A.,
2000]. Also, Galvin, et al., have shown that granzyme B complexes with serglycin are
proteolytically active and able to induce apoptosis [Galvin, et al., 1999].
Calreticulin is also stored in cytotoxic granules. This molecule is a chaperone
protein of the endoplasmic reticulum (ER) and is the only resident ER protein known to
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exist in CTL granules. Fraser et al., have recently shown that calreticulin inhibits
perforin-mediated target cell damage, but not by direct interaction with perforin. The
inhibition works by sequestering calcium, or by inhibiting granzymes. Therefore,
calreticulin could act as a regulatory molecule to prevent premahire activation of perforin
and stabilize granules [Fraser, S.A., et al., 2000; Russell and Ley, 2002].
In addition, it has been shown that the Fas ligand (FasL) appears to be stored in
the same cytotoxic granules that contain perforin and granzymes [Bossi and Griffiths,
1999; Russell and Ley, 2002]. And that the Fas ligand may in fact be delivered to target
cell Fas receptors via the same granules that deliver other granule components (Figure
1.1). This mechanism could be important for sequestering Fas ligand in the effector cell,
to prevent it from causing suicide as it interacts with the receptor intracellulary. But the
relative importance of Fas ligand in the cytotoxic granules has not yet been fully explored
[Russell and Ley, 2002].
Another protein inside the cytotoxic granules is CTLA-4. CTLA-4 was originally
identified as a gene selectively expressed in CTLs and has been recognized to function as
a negative regulator of T lymphocyte activation. It is rapidly but briefly expressed on T
cell surfaces after activation. After exposure on the surface membrane, CTLA-4 is
rapidly reintemalized via clathrin-coated vesicles which recycle the CTLA-4 to the
granule-associated secretory compartment [Henkart, P.A., 2000].
Finally, the other granule protein is called granulysin. Granulysin is a relatively
new type of granule mediator which has been described in both NK cells and human
CTLs. It has been suggested that granulysin plays a role in target cell damage by the
antimicrobial clearance ofmicroorganism, as mentioned in the NK section. Granulysin,
15
like perforin and the granzymes, is synthesized during T cell activation and is thought
to be packaged in the same cytotoxic granule compartment. As mentioned above,
granulysin can cause target cell membrane damage directly and also can cause
mitochondrial depolarization and the release of cytochrome C without activating
procaspase 9, but activating caspase 3 [Kaspar, A.A., et al., 2001]. The importance of
granulysin for CTL function has not been identified yet, as well the murine relative of
this molecule [Russell and Ley, 2002].
1.5.1.1 Perforin
Perforin is a glycoprotein of 534 amino acids with sequence homologous to the
membrane attack complex-forming complement component C9. The protein monomers
are stored in close association with proteoglycans within the electron dense granules
present in CTL effector cells, and they are released upon binding and recognition of
target cells [Millard, et al., 1984; Henkart, P.A., 1985; Podack, E.R., 1986; Podack, E.R.,
2000]. Granules isolated from various cytotoxic effector cells are capable of inducing
cytolytic effect and forming membrane lesions during the lytic reaction [Podack, et al.,
1985; Criado, et al., 1985; Young, et al., 1986; Podack, E.R., 2000]. Secreted perforin
binds to the target cell membrane through a calcium-dependent interaction with
phosphorylcholine head-groups on the target cell membrane, and undergoes a
conformational change to expose an amphipathic domain [Tschopp, et al., 1989]. This
change enables perforin to insert into the lipid bilayer and polymerize to form tubular
transmembrane pores (polyperforin).
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To form adequate and fimctional pore 3-4 monomers is sufficient, while 10-20
aggregated monomers are needed to produce a pore that is visible by electron microscopy
(EM), with a 5-20 nm internal diameter. This may occur only when sufficiently high
concentrations of perforin are available locally [Young, et al., 1986; Kagi, et al, 1996;
Liu, et al., 1995; Podack, E.R., 2000].
Polyperforin inserted into nucleated cells causes rapid and sustained membrane
depolarization. The effect on cell viability is perforin dose-dependent; at high doses of
perforin, cells do not recover from the membrane depolarization due to the influx of
water and ions, killing the cell by lysis due to the membrane damage caused by perforin.
At lower perforin doses, cells may survive through active membrane repair if the perforin
dose does not exceed the repair capacity of the cell. Endocytic repair is dependent on
calcium [Carney, et al., 1986]. Perforation of target cell membrane provokes the
endocytosis leading to pinching off and elimination the damage membrane. Therefore, if
calcium is chelated or excluded, the membrane repair process will be blocked, resulting
in an increase in sensitivity of target cells to pore formers [Podack, E.R., 2000].
Calcium-dependent repair of perforin pores by endocytosis results in the
pinocytosic uptake of fluid containing granzymes if perforin is secreted by granule
exocytosis. The combination of perforin with granzymes in the cytolytic granules of
CTLs and NK cells confronts the target cell upon attack with a critical choice: repair
perforin membrane lesions and uptake of granzymes causing apoptosis or direct death
due to membrane depolarization and loss of ionic equilibrium (lysis). This deadly
combination therefore does not require compliance of the target cell and distinguishes
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perforin mediated killing from apoptotic processes, due to Fas and Fas ligand (FasL)
pathway.
The importance of perforin for cell-mediated cytotoxicity is supported by
perforin-deficient mice experiments. These mices were unable were to clear certain viral
infections and had a reduced capacity to control tumor growth [Kagi, et al., 1994;
Greenberg and Litchfield, 1995].
Perforin was originally believed to be exclusively responsible for target cell death
via the granule exocytosis pathway, a view that has been modified with increased
recognition of the importance of granzymes. Regardless of controversy as to the details
of death by granule exocytosis there is agreement that perforin is necessary for target cell
damage.
A hallmark property of perforin is its ability to form pores in membranes; but the
mechanism by which perforin forms a membrane pore is still not completely understood.
Electron microscopy shows that the maximal pores appear large enough to allow passage
of sizeable proteins. Based on conductance studies and osmotic protection assays,
perforin is reported to form pores of 5 to 20 nm, allowing diffusion of large fluorescent
markers up to 17 kDa. As mentioned above, an ion channel requires three or four
monomers, but a greater number are required to form pores that allow diffusion of the
fluorescent marker. Interestingly, the first 34 amino acids of the N-terminus of the
perforin protein appear to form small-diameter pores. The pores formed by the peptide
allow the influx of Ca killing tumor cells, but erythrocytes are not lysed [Ojcius, et al.,
1991]. This suggests that other domains of the perforin protein may be necessary to
facilitate formation of the larger pores that cause hemolysis [Froelich, C.J., 2000]. Shiver
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and Henkart in 1991, suggest that both purified perforin and complement are much
more active in lysing red blood cells than nucleated cells. One explanation, as mentioned
above, is that nucleated cells can rapidly endocytose patches of membranes containing
inserted perforin, thereby avoiding diffusion of ions across the membrane and the
consequent osmotic lysis. Endocytosis by target cells can also result in the internal
transport of surface-bound granzymes, and it has been proposed that this is the
physiologic route of granzymes entry to the cytoplasm from endosomes [Henkart, P.A.,
2000]. However, depending on the pore size, perforin may have different biologic
effects: prior to removal from the membrane e.g., small pores may be responsible for
lytic necrosis [Froelich, C.J., 2000].
Presently, perforin has been established as the primary effector molecule against
intracellular pathogens. Its cooperation with granzymes makes it a powerful mechanism
for lysing cells through membrane damage and triggering apoptosis. Perforin deficiency
results in increased susceptibility to a variety of viral infections and is associated with
delayed tumor clearance in a variety of whole animal systems [Kagi, D., et al., 1996;
Russell and Ley, 2002]. In addition to this primary function, perforin contributes to
immune regulation and homeostasis. As revealed in graft-versus-host diseases (GVHD),
perforin accelerates the allogenic immune response, most likely through the lysis of
target cells and release of antigens. FasL-mediated apoptosis may not have the same
effect because death by this pathway may downregulate antigen presentation [Podack,
E.R., 2000; Russell and Ley, 2002]. Perforin also downregulates immime function
through the killing of APCs. This function normally is performed by FasL-inducing
apoptosis of APCs following T cell activation. However, in absence of FasL, perforin
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can substitute for this function to some extent. Because in absent of both effectors,
severe autoimmunity ensues and causes early death [Podack, E.R., 2000].
1.5.1.2 Granzvmes
Other molecules involved in the cytolytic process are granzymes. They were first
reported as CTL/NK specific serine proteases by Pasternack, et al., in 1986. Standard
nomenclature refers to these as granzymes A-G. The term granzyme refers to their
localization in the cytoplasmic granules of CTL/NK cells and to their release during
granule exocytosis [Pasternack, et al., 1986; Ojcius, et al., 1991; Greenberg and
Litchfield, 1995]. By 1995, seven mouse granzymes A-G have been identified [Lowin, et
al., 1995; Froelich, C.J., 2000]. These enzymes have several distinct proteolytic
specificities. Granzyme A cleaves proteins after the basic amino acids arginine (Arg) or
lysine (Lys). Granzymes B cleaves proteins after the aspartic acid (Asp); granzymes D,
E, F, and G have a preference for cleavage ay hydrophobic amino acids [Odake, et al.,
1991; Shi, et al., 1992; Lowin, et al., 1995; Henkart, P.A., 2000]. They are expressed
upon stimulation of lymphocytes to differentiate into cytotoxic effector cells.
Members of this family have been purified and characterized as active proteases
by hydrolysis of synthetic substrates [Shi, et al., 1992]. Granzyme A has a structure
which is unique among serine proteases, because it forms a disulfide-linked homodimer
of approximate 50 kDa. Granzymes B-G consists of a single polypeptide chain which
molecular weight varies between 27 and 32 kDa [Shi, et al., 1992; Greenberg and
Litchfield, 1995]. These serine proteases are highly homologous having at least 39%
amino acids identity. All of these contain, at equivalent positions, three characteristics
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residues, histidine (His), aspartic acid (Asp) and serine (Ser), characteristic of the
catalytic triad of serine hydrolases [Lowin, et al., 1995].
As mentioned in previous sections, the original ideas about the collaboration
between perforin and granzymes for the induction of cell death have evolved
considerably. The idea that perforin created a channel through which granzymes could
pass was widely held in 1996. However, the channels created by polyperforin range in
size up to 20 nm which, depending on the pore size, could not be large enough to permit
diffusion of even small proteins {i.e., 8 kDa) into cells [Browne, K.A., et al., 1999]. The
granzymes range in size from approximately 30 to 65 kDa, and they are probably
complexes with serglycin upon secretion. These observations suggested that the
granzymes cannot enter target cells directly via a perforin pore. But a second hypothesis
for granzyme entry, namely reparative endocytosis, was offered to explain this situation
(Figure 1.2). In this model, perforin entry into the target cell membrane created a signal
for the target cell to repair the damage by endocytosing the perforin and surrounding
plasma cell membrane; granzymes in the vicinity of the lesion are also endocytosed and
ultimately delivered to the target cell cytoplasm and nucleus, where they activate the
apoptotic cascade.
Several groups have now demonstrated that purified granzymes B can enter target
cells without any chaperones or perforin [Russell and Ley 2002]. In this model,
granzymes B enters the target cell by advantage of its binding to the cation-independent
mannose-6-P receptor. After the receptor is internalized, the granzymes B is released
into and endolysosomal compartment where it is rendered harmless.
Figure 1.2 Perforin-Induced Repair Endocvtosis.
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Granzyme release
Perforin-induced repair endocytosis is triggered by Ca influx, followed by removal of
the membrane pore and uptake of granzymes. Polyperforin-containing endosome
resistant to proteolytic removal is generated. Polyperforin pore prevents acidiflcation and
fusion with lysosome. The sequence ends by release of granzymes and triggering of
apoptosis [Podack, E.R., 2000].
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Granzyme B later leaves the compartment, where it can then cleave cytoplasmic and
nuclear apoptotic substrates. After granzyme B is released from its endolysosomal
compartment, it is apparently rapidly trafficked to the nucleus. Granzyme B in the target
cell initiates cell death by cleaving a variety of protein substrates that are either directly
or indirectly linked to the induction ofDNA fragmentation and cell death. Over the past
several years, many studies have clearly shown that a number of procaspases (including
caspases 2, 3, 7, 8, 9 and 10) are substrates of granzyme B both in vitro and in vivo
[Russell and Ley, 2002]. Also a large niimber of studies have evaluated the requirement
of caspases for granzyme B’s ability to induce target cell apoptosis. Currently, several
pathways have been identified for granzyme B action in target cell. After granzyme B
enters target cells, it cleaves and activates procaspase 3 (and several other procaspases),
Bid, and ICAD (inhibitor of CAD), a molecule which exists as a heterodimer with CAD
(caspase-activated DNAse). The granzyme B proapoptotic signal is amplified by caspase
activation and/or Bid cleavage and translocation to the mitochondrial membrane, where
Bax and Bak then form a channel that permits cytochrome c release. Granzyme B is also
capable of directly acting on mitochondrial membranes to cause depolarization in the
absence of cytochrome c release. All of these pathways initiate either DNA
fragmentation or apoptosis in the target cell [Russell and Ley, 2002].
Granzyme A was the first serine protease to be discovered in cytotoxic granules
[Pasternack, et al., 1986; Russell and Ley, 2002], but not much is known about its
mechanism of action in inducing cell death in comparison to granzyme B. Granzyme A
is a tryptase and prefers to cleave at the carboxyl side ofArg or Lys. It exists in granules
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as a disulfide linked homodimer, coraplexed with proteoglycan, as mentioned above.
After granzyme A is release from activated CTL, it can circulate in an active form, bound
to proteoglycans that protect it from inactivation by proteins like a2-macroglobulin
[Russell and Ley, 2002]. When delivered to target cells with perforin, purified gran2yme
A can clearly induce target cell apoptosis [Shi, et al., 1992]. But the timing of cell death
induced by granzyme A, is much slower than of granzyme B, because granzyme A
requires many hours to induce apoptosis. The reasons why granzyme A induces death so
slowly are unknown. But Russell and Ley in their 2002 review speculate that they could
include: (a) a proteolytic cascade that involves a large number of enzymes and substrates,
and /or (b) a very slow catalytic rate for one step in death induction, or (c) a specialized
compartment of granzyme A-expressing CTL that delivers its death signals more slowly
than cells that deliver granzyme B. However, all of these potential mechanisms need to
be explored. Putative targets for granzyme A have been extensively studied. For
example: granzyme A is known to bind and cleave nucleolin and to cleave and activate
interleukin-ip. Granzyme A binds to heat shock protein 27 in target cells but does not
cleave it [Shiver, et al., 1992; Lowin, et al., 1995], and also enhances DNA accessibility
to endonucleases by degrading histone-Hl. Finally granzyme A directly cleaves lamins,
thus may disrupt the nuclear lamina and cause nuclear breakdown [Russell and Ley,
2002].
The cellular pathways used by granzyme A to induce cell death appear to be
independent from those utilized by granzyme B. Apparently, Granzyme A does not
activate caspases in target cells or cleaves substrates like poly (ADP-ribose) polymerase.
Furthermore, granzyme A induced death does not cause oligonucleosomal DNA
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degradation, bur it appears to cause single stranded DNA breaks, which suggest that
granzyme A activates different nucleases than granzyme B [Russell and Ley, 2002].
Although there are no data to support this hypothesis yet, Russell and Ley, 2002,
speculate that the rest of the murine granzymes downstream from granzyme B may
certainly subserve specialized functional roles for murine CTLs, in the induction of target
cell death in specific physiologic conditions.
1.6 The Fas-Mediated Apoptosis Pathway
In 1994, perforin-knock out mice experiments served to clarify the second lytic
pathway in CTLs [Kagi, et al., 1994 a,b; Lo\vin, et al, 1994; Kagi, et al., 1996], This
second pathway is the Fas-based killing (apoptosis) mechanism; triggered by the binding
of Fas ligand (Fas L) on CTLs with the Fas receptor molecules on the target cell, which
in most cases accounts for approximately 25% of lysis in short termed assay [Lowin,
Peitsch and Tschopp, 1995]. Cell death by apoptosis is clearly different from necrosis.
In necrosis, after the cell is damaged, the cell volume increases, and is followed by cell
and organelle membrane rupture. This can be tracked by staining with vital dyes such as
Tryptan blue or Propidium iodide. After the cell bursts, internal materials are released to
the extracellular space where products such as mitochondrial proteins provoke an
inflammatory reaction characteristic of necrotic cell death [Wyllie, A.H., 1997; Duke, et
al., 1996; Williams, et al., 1992].
Cell death by apoptosis presents structural features such cell shrinkage, blebing,
condensation of the cytoplasm, increase in cell density, compaction of cytoplasmic
organelles, and most important DNA degradation and condensation of nuclear chromatin.
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Subsequently, cells fragment into a cluster of membrane boimded bodies, each
containing a variety of organelles. These apoptotic bodies, since their membranes remain
intact, do not stain with vital dyes.
Apoptotic cells and bodies within tissues or in vitro are efficiently phagocytosed
by their viable neighbors or by specialist phagocytes without release of cell contents,
explaining why this process does not provoke an inflammatory response [Wyllie, A.H,
1997; Duke, et al., 1996],
The Fas pathway appears to be active in all killer cells but most important for the
CD4‘^ cells, especially those of the Thl phenotype. An important difference between the
Fas pathway and perforin-granzyme initiated pathways is the speed of the cytotoxic
event. Once formed, granules can be reoriented and released within minutes of TCR
stimulation. In contrast, very little FasL is stored, even in activated cells. Therefore,
maximal activity requires the induction of new ligand over a 1-2 hour period after TCR
stimulation. Induction of new ligand continues as long as there is TCR stimulation and
FasL is cleared from the surface either by proteolysis or by endocytosis, depending on the
effector cell. This clearance of ligand on the surface occurs with a half life of 2-3 hours.
The long half life of the ligand on the surface allows effector cells to continue to display
cytotoxic activity in the absence of TCR stimulation and could leads to the phenomenon
of bystander killing (see next section). This implies that cells in the vicinity that express
Fas, are killed, even if they do not express the antigen recognized by the TCR.
Therefore, the Fas pathway can be less accurate than the perforin-granzymes initiated
pathways [Russell and Ley, 2002].
1.6.1 Fas Molecule
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Fas is a cell surface protein that was recognized by monoclonal antibodies in
1989, independently by two laboratories [Trauth, et al., 1989 and Yonehara, et al., 1989].
The surface molecules were called Fas and APO-1. Fas molecule was recognized by
binding of an immunoglobulin M (IgM) antibody (anti-Fas). Binding of mouse
antibodies lead to cell death by DNA fragmentation following by cell phagocytosis
[Matiba, et al., 1997]. The antibody to APO-l/CD 95 was an IgGa. Molecular cloning
showed that APO-1 was the antigen, the Fas receptor, to which Fas ligand binds. Several
cell types express Fas, but Fas ligand (Fas L) is expressed predominantly in mature T
cells (active). Fas and FasL are involved in the regulation of immune reactions and also
in T cell-mediated cytotoxicity. Failure or malfunction of the Fas pathway leads to
various pathologies including carcinogenesis, autoimmune diseases, or tissue destruction
[Nagata and Golstein, 1995; Duke, et al., 1996].
In 1995, Nagata and Golstein determined the structure of Fas. They reported that
Fas belongs to the Tumor Necrosis Factor (TNF) receptor family. Members of the TNF
receptor family are classified as transmembrane proteins class I, meanwhile their ligands
are classified in the TNF cytokine family. TNF receptor family have other two members
tumor necrosis factor receptor 1 and 2 (TNF-Rl) (TNF-R2), where the last one induces
cell activation conversely TNF-Rl and Fas that activates the suicidal cascade.
The members of this family have in common three to six cysteine-rich domains.
The amino acid sequences of the members were also examined. The sequence was
conserved in the extracellular region, but not in the intracellular region. Two members,
TNF-Rl and Fas, are homologous in the 70 amino acids, intracellular domain. The
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conservation of these sequences in the cytoplasmic domain suggests that they may be
necessary and sufficient for the transduction of the apoptotic signal. Therefore, this
domain has been referred to as the death domain [Wyllie, A.H., 1997; Matiba, et al.,
1997; Golstein, P, 2000].
Fas ligation in target cells activates a complex signaling cascade consisting of
molecules such as the Fas receptor CD95, the death initiating signaling complex (DISC),
the Fas-associated death domain (FADD) and the FADD-like ICE (FLICE) molecules
which turn on the caspases cascade. Caspases (for cysteine-containing asp-ases) also
called ICE-like (from homology to ICE, Interleukin ip-Converting Enzyme) [Whyte, M.,
1996; Wyllie, A.H., 1997; Golstein, P., 2000] are activated during initiation of apoptosis.
They are possibly responsible for all the structural changes in the nucleus during
apoptosis. Caspases also can activate other enzyme by proteolytic cleavage and this
process can affect cytoskeleton proteins, for example: actin, and the integrity of the
nuclear envelope through the lamins. The activation of the caspases cascade during
apoptosis initiates a proteolytic cascade that disrupts the normal function of proteins and
especially the structure of the cell. This recent model offers a logical explanation for the
rapid/near simultaneous changes all over the cell during apoptosis [Wyllie, 1997; Duke,
et al., 1996].
1.7 Bystander Lvsis bv CTLs
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One of the most important properties of the T-Cell immune response is its
specificity, directed at elimination of antigen-bearing cells. This specificity includes the
target cell destruction by cytotoxic T cells (CTLs). CTLs form contacts with
surroundings cells, as they search for the specific antigen on presenting cells. But CTLs
generally do not damage these cells, they only recognize and destroy target cells infected
with virus or neoplastic cells. After CTLs have formed cognate conjugates, they deliver
the lethal hit to the target cell.
During the hunt for antigen presenting cells, it is assumed that “innocent
bystanders,” a term that includes all cells not expressing antigen, are not recognized, and
therefore, are not injured or killed by CTLs [Kojima, H., and Sitkovsky, M., 2000].
Where bystander lysis a commonplace occurrence, every infection would be
accompanied by severe immunopathologic reactions and damage to local tissue.
However, in vitro experiments have demonstrated the possibility of bystander lysis under
artificial conditions. Lanzavecchia in 1996 reported that antigen non-expressing targets
could be killed if they are bridged to antigen-activated CTLs by their own receptors.
Also Duke and coworkers observed in their 1989 studies that CTLs could lyse only
syngeneic bystander. This lysis was explained as being due to self major
histocompatibility complex (MHC) recognition by CTLs on activated CTLs. For
bystander killing, one would expect perforin to diffuse to neighboring cells. But this does
not seem to occur. Microscopic examination of CTL-target conjugates indicates
orientation of secretory granules toward the poles of conjugates. This may focus delivery
ofperforin and granzymes into the synaptic space. In contrast, other cytotoxic cells such
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macrophages that secrete soluble toxins, reactive oxygen and NO do indeed kill
bystander and effectively sterilize their local environment. In the last decade,
investigations led us to a better understanding of the Fas-mediated death pathway in Fas-
expressing cells. Also, the effort led in the conclusive demonstration published in 1994
of perforin and Fas-mediated mechanism of CTL cytotoxicity [Kojima, H., et al.; Kagi,
D., et al.; Lowin B. et al.; and Walsh, C.M., et al.]. These demonstrations have led to the
expectation that bystander target lysis by CTLs should be more important than is
currently understood. Therefore, it was important to determine whether and to what
extent CTLs killed antigen free bystanders during lysis of specific antigen-bearing cells,
in other words, to check whether the presence of non-antigen bearing cells near
interacting CTLs and antigen-expressing target cells make them vulnerable to
“bystander” lysis. Experiments reported by Kojima, H., et al., 1997 and Gromkowsky,
S.H., et al., 1988 and Wang, R., et al., 1996, determined that all vulnerable bystanders
tested expressed Fas, but resistant bystanders did not, suggesting the importance of the
Fas antigen expression on bystander cells and the involvement in the Fas L/Fas mediated
pathway of target cell death.
Also it has been reported by Kojima, H., et al., 1994; Vignaux, F., et al., 1995 and
Dustin, M., et al., 1991, that the vulnerability of bystanders to CTL is time sensitive and
LFA-1 dependent. All the observations are consistant with the observations made by
Lancki, D.W., et al., 1987 and Smith, M.J., 1997, which help them to develop a model of
the time-dependent, Fas-dependent, ICAM-1-dependent, antigen-expressing cell-
dependent lysis of bystander by antigen-specific CTL. The model indicates that most
cells are not vulnerable to CTLs when they lyse neighboring antigen-expressing targets.
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Also several important conditions must be satisfied before the antigen non-expressing
bystanders become susceptible to the CTL lethal hit. These include presence Fas on
bystanders and Fas ligand on the correspondent T cells. However, not all tissues express
Fas. Secondarily, bystanders must express ICAM-1 molecule, which also is not
expressed on all cells. Finally bystanders must be in the vicinity of CTL, the aggressor,
because CTLs remain active for no more than 2 hours after seeing the Ag-TC. Thus,
these are several causes for limiting, minimized and terminating bystander lysis by CTLs,
so the collateral damage during a normal CTL response is regulated and controlled
[Kojima, H., and Sitkovsky, M., 2000].
1.8 The Role ofPerforin-Mediated Cvtolvsis in Tumor Surveillance
Natural killer (NK) cells contribute to the host defense mechanism by lysing
virus-infected cells or tumor cells in an antigen-nonspecific way. In contrast to cytotoxic
lymphocytes (CTLs), which need several days to be activated, NK cells can be activated
within hours by interferon (INF) y/p or by interleukin-12 (IL-12). Thy lytic activity of
NK cells is regulated both by activating and inhibitory molecules. Major
histocompatibility complexes class I (MHC-I) molecules on target cells have been shown
to bind to NK inhibitory receptors, (Ly-49 family), thus preventing the lytic activity of
NK cells. Since viral infection often inhibits proteins synthesis in general, or interferes
with the export ofMHC-I molecules, virus-infected cells may become resistant to CTL-
dependent lysis and become susceptible to NK-dependent lysis instead. Tumors are
known to downregulate the expression of MHC-I molecules to escape immune
surveillance, consequently making themselves a target for NK cells [Van den Broek, et
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al., 2000]. To explore this area Van den Broek, et al., used a perforin-deficient (PKO)
mouse to study the involvement of perforin and Fas ligand in tumor siuv^eillance in vivo.
They learned that several mechanism may control tumor growth; perforin-mediated
cytotoxicity by CTLs (for MHC-I tumors) and NK cells (for tumors expressing low levels
ofMHC class I) are ofmajor importance. Fas/FasL interactions can contribute to tumor
control in vivo, although to a lesser extent than perforin-dependent lysis, at least in tumor
models used in their system: lymphoid [MBL-2 (B cell lymphoma), EL-4 (thymoma)]
and non-lymphoid [MC57G (fibrosarcorma)] [Van den Broek, et al., 1996 and 2000].
1.9 Reviewing the Resistance ofCTL to Perforin-Mediated Lvsis
When CTLs kill target cells, they secrete perforin and expose their own
membranes to its cytolytic effects. Nonetheless, CTLs survive the encounter and proceed
to kill other available targets. CTLs are highly resistant to perforin and, therefore,
survive exposure to their own secreted perforin. Studies suggest that components of
CTLs membranes interfere with the insertion ofperforin and formation of transmembrane
channels [Verret, et al., 1987; Jiang, et al., 1988; Shinkay, et al., 1988; Jones and
Morgan, 1991]. CTLs bind perforin less readily than do other cell lines [Verret, et al.,
1987; Ojcius, et al., 1991]. Some data suggest that perforin assumes different
conformations upon interacting with membranes of sensitive cells as opposed to those of
resistant CTLs [Muller and Tschopp, 1994]. The membrane factors protecting CTLs,
however, have not been identified, but some advances have been published recently.
The notion that the mechanism(s) of self-protection of killer lymphocytes is (are)
limited to the plasma membrane was suggested by patch-clamp experiments performed
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either in the whole cell configuration or in right side-out excised membrane patches
[Persechini, et al., 1990; Jones and Morgan, 1991]. Perforin, at doses sufficient to induce
large conductance changes in membranes of susceptible cell lines, did not increase the
conductance in resistant cell lines, indicating the absence of channel/pore formation.
Furthermore, cytoplasts (“cells” depleted of intracellular organelles and nucleus) derived
from killer lymphocytes remained refractory to perforin-mediated membrane damage
[Ojcius, et al., 1991]. The latter study indicates that the intracellular components,
including cytoplasmic granules, are not necessary for the resistance to perforin. These
results, taken together, suggest that the inhibition of pore formation in the plasma
membrane may be the most important event in the self-protection of killer lymphocytes
(CTLs).
Studies performed during the early 90s suggested that protein(s) present
specifically on the surface of CTLs, which had been named “protectin’’ may be
responsible for the resistance of these cells to perforin-mediated cytolysis [Jiang, et al.,
1990 a,b; Liu, et al., 1995]. Protectin is thought to be involved in abolishing the insertion
and/or polymerization of perforin molecules that diffuse backwards and may potentially
bind to the surface of CTLs. If this self-protection mechanism were correct, CTLs would
bind quantitatively fewer perforin molecules than the susceptible target cells in whose
membranes multiple perforin molecules could insert and aggregate. Lui, et al., and others
have observed in an indirect competition assay that indeed the susceptible target cells but
not the CTLs adsorbed perforin, in that way reducing the amount of perforin available to
lyse red blood cells co-present in the reaction mixture [Verret, et al., 1987, Jiang, et al.,
1990 a,b]. Moreover, treatment of CTLs with proteolytic enzyme, trypsin, rendered them
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capable of binding more perforin, resulting in the inhibition of the lysis of red blood
cells in the competition assay [Jiang, et al., 1990a]. Likewise, treatment with
tunicamycin, an inhibitor for N-glycosylation and cleavage of sialic acid from protein
with neuraminidase also made CTLs bind perforin [Jiang, et al., 1990a]. The findings in
the latter experiments were interpreted to suggest that the putative protectin responsible
for preventing aggregation of perforin in CTLs membrane is probably glycosylated
(Figure. 1.3). On the other hand, steric factors or shielding of membrane may explain
these results.
Figure 1.3 Hypothetical Model for Self-Protection ofCTLs Against Perforin.
LIUETAM
Hypothetical model for self-protection of CTLs against perforin damage. Perforin
released from CTLs (K) may bind, insert into the membrane of target cell (T) in which
perforin monomers aggregate to form pores. Perforin monomers which diffuse toward
the CTL may encounter inhibitory factor “protectin” (?). The binding of perforin
monomers to “protectin” could render them incapable of subsequent self-polymerization
[Liu, et al., 1995].
34
On the other hand, two other groups have reported that CTLs bound perforin equally well
as did non-killer cells [Jones and Morgan, 1991, Muller and Tschopp, 1994]. One of the
two groups proposed that a protective molecule present on CTL surface may interact with
perforin monomers which have bound to the membrane, rendering them lytically inactive
by inducing certain conformational changes incompatible with the subsequent pore
formation [Muller and Tschopp, 1994].
Although the evidence and the two models described above imply the
involvement of a surface membrane-associated mechanism in the self-protection of
CTLs, it would be useful to isolate and identify the putative protection molecule to clarify
the molecular basis for perforin resistance. Results from Liu, et al., 1995, have suggested
that protectin appears to be unrelated to perforin, since they have observed that certain -a
CTLs and CTL hybridomas expressed no detectable perforin, and lymphokine-activated
killer (LAK) cells prepared from perforin-deficient mice were still resistant to perforin-
mediated lysis [Liu, et ai., 1995].
The question arises whether other mechanisms protecting CTLs from lysis by
perforin exits. Another hypothesis suggests that cytotoxic granules are secreted
vectorially by target cell-activated CTL into the synaptic cleft between the CTL-target
cell conjugates. This local delivery mechanism of granules and perforin is responsible
for the ability of CTLs to unidirectionally kill target cells without damaging themselves
[Henkart, 1985; Nagler-Anderson, et al., 1988; Podack, 2000]. Several factors are
postulated to guarantee the unidirectionality of the lytic attack (Figure 1.4) (1) Once
exposed to extracellular calcium the half-life ofperforin is extremely short, allowing only
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very short distances for diffusion in the active form. (2) Diffusion is further restricted
by the proximity of the membranes and a high density of adherence receptors
surroimding the synapse. (3) Perforin is secreted in a large supramolecular complex of
proteoglycan associated also with granzymes and diffusion is further restricted by the
high molecular mass of the complex. (4) Physical constraints may limit diffusion and
access ofperforin. Only the target membrane is exposed to perforin. The CTL side may
be coated with proteoglycan, blocking perforin access. In this model restriction of
perforin killing to target cells is dictated by the physical constraints of granule release to
the target cell (Figure 1.4). The only part of the killer cell potentially coming into contact
with perforin is the specialized granule membrane [Podack, 2000].
Figure 1.4 Vectorial Releases of Granules.
Restriction ofperforin to target lysis and CTL (K) self-protection by physical constraints.
Perforin diffusion is restricted by adhesion molecules via binding to proteoglycan
complexes and rapid inactivation [Podack, E.R., 2000].
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The idea of a membrane protein, described earlier, that interacted with perforin,
providing a mechanism for CTL to protect themselves from perforin damage, was
examined more recently by Rochel and Cowan, 1997. They explored the role of lipid
packing on perforin activity as a mechanism for protecting CTL from perforin-induced
membrane damage. They found that insertion and aggregation of perforin peptides was
more facile in membranes with less densely packed lipids [Rochel and Cowan, 1997;
Russell and Ley, 2002].
The concept of a perforin receptor has been also explored in two recent
publications. Berthou et al., 2000, suggested that NK cells can release the lysolipid
platelet activating factor (PAF), which may act as a chaperone for perforin. PAF
receptors were found on perforin-sensitive cell lines, but not on perforin-resistant lines;
interferon-y induced PAF receptor expression correlated with the induction of perforin
sensitivity. They concluded that failures of interferon-y to induce membrane PAF
receptor could make tumor cells resistant to perforin-mediated attack or lysis [Berthou et
al., 2000; Russell and Ley, 2002]. A similar idea was separately explored by Lehmann,
et al., 2000, who indicated that human leukemia cell line (ML-2), showed resistance to
NK-mediated killing associated with ability of perforin to bind the surfaces of cell. They
conclude that perforin resistance could represent and important tumor escape mechanism,
especially when CTLs are used for cellular immunotherapy [Lehmann, et al., 2000;
Russell and Ley, 2002].
Even though the CTLs protection mechanism discussed above could be correct,
the possibility that other mechanism involving membrane repair by endocytosis of
perforin pores or other unidentified intracellular machinery should not be underestimated.
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Such mechanisms are presumably energy-consuming and would require the functioning
of the cytoskeleton of CTLs. But observations made by several investigators between in
the late 80s and early 90s, already suggested that these mechanism are unlikely to be
involved. For example studies performed by Verret, et al., 1987 and Nagler-Anderson, et
al., 1988, have shown that ATP-depletion of CTLs by cyanide, sodium azide and 2-
deoxyglucose treatment did not affect their resistance to granule or perforin-mediated
lysis, suggesting at least that the principal self-protection mechanism(s) of CTLs is not
ATP-dependent [Verret, et al., 1987; Nagler-Anderson, et al., 1988; Liu, et al., 1995].
Also, studies by Ojcius, et al., 1991a, using cytoplasts and cytochalasin B-treated CTLs
indicated that intact cytoskeleton is not required for the expression of resistance to
perforin by CTLs [Liu, et al., 1995]. Membrane rearrangement may not be involved in
the resistance of CTL to perforin mediated lysis. But for the target cell, this mechanism
is proposed for their resistance to perforin-granzyme cell death or their escape to CTLs
immune-surveillance. Other work has demonstrated that target cells can mitigate the
effects of perforin through various repair processes, including endocytosis of perforin
channels and restoration of ionic gradients [Allbritton, et al., 1988; Jones, et al., 1990,
Podack, 2000]. These repair processes may be enhanced in CTLs and serve to protect
them during interactions with target cells. This is one of the concerns addressed in this
dissertation.
To examine the resistance of CTLs this laboratory has explored different factors:
one of them how heat stress can affect the resistance of cells to CTLs lysis [Jackson, et
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al., 2000]. Another issue is whether tumor cells arrested in distinct phases of the cell
cycle differ in their susceptibility to perforin-mediated lysis [DeLeon, et al., 1998].
This laboratory has shown that A20 lymphoma cells which were subject to heat
shock at 42°C caused little change in sensitivity to lysis by intact CTLs or their cytotoxic
granules, but caused increased sensitivity to lysis to Fas-mediated apoptosis [Jackson, et
al., 2000]. However, A20 cells shocked at 43°C declined significantly in sensitivity to
lysis by intact CTLs, while remaining very sensitive to perforin granules and to Fas-
mediated apoptosis. Expression of the inducible heat shock protein was observed in A20
cells incubated at 43°C, but not in those incubated at 42°C, suggesting a role for heat
shock proteins. In addition, A20 cells shocked at 43°C did not provoke degranulation and
secretion of granzymes by antigen-specific CTLs, although formation of CTL-target
conjugates and levels of MHC class I molecules remained imchanged. These
observations demonstrated that hyperthermia or feverish conditions may reduce
susceptibility of target cells to CTL attack due to failure of antigen presentation and the
inability of CTLs to recognize teat stress targets, thus enabling targets to escape CTL
attack [Jackson, et al., 2000].
This laboratory also has demonstrated that A20 (B-lymphoma) and P815
(mastocytoma) cell lines arrested at the Gi/S interface of the cell cycle by inhibition of
DNA synthesis with thymidine or aphidicolin are less susceptible to perforin-mediated
lysis [DeLeon, et al., 1998]. In contrast, growth arrest with thymidine or aphidicolin
increased susceptibility ofA20 and P815 cells to Fas-mediated apoptosis. Susceptibility
to lysis by intact CTLs was not affected significantly by blockade of target cells with
aphidicolin or thymidine. When cells surviving exposure to perforin-containing granules
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were isolated on Ficoll density gradients and cell-cycle profiles were examined by flow
cytometry, the ratio ofGi to Ga cells increased among the survivors exposed to granules
in contrast to controls incubated with buffer alone. The data suggest that cells in Gi
phase of the cell cycle are less susceptible to the perforin pathway than cells in Ga and S
phases, but cells are more susceptible to the Fas pathway [DeLeon, et al., 1998].
1.10 Gangliosides
Glycolipids probably occur in all animal cell plasma membranes, generally
constituting about 5% of the lipid molecules in the outer monolayer. They are also found
in some intracellular membranes. The most complex of the glycolipids are the
gangliosides, from the glycosphingolipids family. These lipids have a glycosidic linkage
to the terminal hydroxyl of the ceramide. The classification scheme is according to the
carbohydrate moiety, which can range from a single sugar to very complex polymers.
Gangliosides are a class of anionic glycosphingolipids that contain one or more of sialic
acid (N-acetylneuraminic acid, NeuNAc) linked to the sugar residues of a ceramide
oligasaccaride [Gennis, R.B., 1989]. Gangliosides are most abundant in the plasma
membrane of nerve cells, where they constitute 5-10% of the total lipid mass, and they
are found in much lesser quantities in other cell types. The functions ofmost glycolipids
are not clear, but much evidence indicates that they are essential for structure and
organization of tissues. Charged glycolipids, such as gangliosides, may be important for
their electrical effects: their presence will alter the electrical field across the membrane
and the concentrations of ions, including Ca^"^ at near membrane surfaces. Thus, they
may modulate the function of membrane proteins. Gangliosides may also play a role in
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electrical insulation, such as in the myelin membrane, which electrically insulates nerve
axons, the noncytoplasmic leaflet of the bilayer is filled with them. Also, gangliosides
are thought to function in cell-recognition processes. The ganglioside GMl, for example,
acts as a cell-surface receptor for the bacterial toxin associated vrith cholera. Cholera
toxin binds GMl to and enters those cells that have GMl on their surfaces, including
intestinal epithelial cells. Although binding bacterial toxin cannot be the normal flmction
of gangliosides, such observations suggest that these glycolipids might also serve as
receptors for normal extracellular molecules. As mentioned above, while gangliosides
functions remain incompletely understood, they can serve as cellular receptors, mediate
cell recognition and adhesion, and transducer growth and differentiation signals to the
intracellular environment. These complex glycosphingolipids can also inhibit a variety of
immune responses through actions on different cells of the immune system [Irani, 1998
and 1996].
The capability of the immune system to recognize and eliminate spontaneously
arising tumor cells is considered important for prevention of tumor formation. But
observations suggest that tumor cells possess mechanisms that allow them to escape
initial immune recognition and destruction. One proposed mechanism of tumor escape is
the release, by tumor cells, of soluble factors into their microenvironment, leading to the
suppression of the immune response. The Ladisch research group has hypothesized that
gangliosides may function as soluble modulators of the iimnune response [McKallip, et
al., 1999]. Evidence that gangliosides may be active in the suppression of the antitumor
immune response includes studies demonstrating that tumor cells synthesized and shed
gangliosides into their microenvironment. Also studies showing that gangliosides are
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highly immunosuppressive in vitro [Li and Ladisch, 1997; McKallip, et al., 1999].
Gangliosides inhibit multiple steps in the cellular immune response, including antigen
processing and presentation, lymphocyte proliferation, and the generation of a cytotoxic
response [McKallip, et al., 1999].
Evidence presented above suggests that membrane proteins, likely glycosylated,
may play a role in protecting T cell, from perforin-mediated lysis.
1.11 Approach
In order to identify factors that make cells less susceptible to perforin
lysis, first the relationship between proliferative status of the cells and the sensitivity to
perforin was examined. A20 and P815 target cells were blocked at the Gj/S interface of
the cell cycle with aphidicolin (aph) and thymidine (thy). In presence of aphidicolin,
cells that have entered S phase can no longer synthesize DNA whereas cells in other
phases continue the cell cycle and stop at the Gi/S border. Aphidicolin inhibits DNA
polymerase a (pol a) (the enzyme that participates in the replication of chromosomal
DNA) by competing vrith dCTP and not with the other three deoxynucleotide
triphosphates (dXTP, dGTP and dATP) [Oguro, et al., 1979]. Studies by Sheaff, et al.,
1991 show that the process of inhibition proceeds through the formation of a pol a -
DNA-aphidicolin ternary complex, that caimot polymerize dNTPs; thereby stopping the
DNA elongation process during replication.
Thymidine at millimolar levels inhibits growth ofmost cultured mammalian cells.
Its toxicity is believed to result from sustained increase in the dTTP levels, which
allosterically inhibits ribonucleotide reductase (the enzyme responsible for reduction of
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NTPs to dNTPs). Suppression of dNTP availability leads to arrest of the cell cycle at
Gi/S. The inhibition of cell growth by deoxythymidine is reversed by deoxycytidine
which increases the dCTP pool, suggesting that dCTP concentration is critical in
controlling DNA synthesis [Fox, et al., 1980],
Cellular proliferation was arrested at the Gi/S interface with either thymidine or
aphidicolin to determine whether cells at different stages of the cell cycle differ in
susceptibility to perforin-mediated cytolysis, Fas-induced apoptosis, and cytotoxicity
mediated by intact CTLs. Studies were performed to determine whether the effects of
cells arrest at the Gi/S interface on perforin-susceptibility, apply also to other membrane-
permeabilizing agents, i.e., streptolysin-0 (SLO) and melittin.
To determine whether perforin resistance of CTLs is related to their proliferative
status, CTLs cells were sorted and isolated by flow cytometry at different stages of their
cell cycle. CTLs were isolated by dissociating the CTL:target cell conjugates with
vortexing. Cells were stained with CTL-specific anti-CD8-PE monoclonal antibody and
target-cell-specific anti-MHCl-FITC monoclonal antibody. The isolated CTLs were
used to determine their susceptibility to perforin.
As described in previous sections, cells can eliminate and recover from perforin
challenge by clearing perforin lesions through endocytosis. Therefore, to determine if the
endocytosis process is enhanced in the Gi/S target cells and in CTLs, flow cytometric
studies were performed using the endocytosis tracer FITC-dextran (FD-10). FD-10 is
taken up into the cells by fluid-phase endocytosis (pinocytosis) and accumulates in the
endosomes.
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Also, as mentioned in previous sections, another hypothesis describes the
resistance of cells to perforin-mediated lysis, especially in the CTLs to a surface protein
or lipid, which interact with perforin and inhibit formation of lesions. In order to start
exploring this question, gangliosides were isolated and purified from tissue culture cells.
Gangliosides from membranes of various cells were analyzed by HPTLC and detected by
Resorcinol-HCl method. A comparison between A20, P815, YAC-1, and CTLL-2 was
performed by metabolic labeling vvith '‘’C-labeled sugars.
To our knowledge, no examination of the effects of cell cycle on susceptibility to
perforin has been described, besides the ones reported from this laboratory. In this study,
cells have been arrested at the Gi/S interface or isolated at different points of the cell
cycle to determine the susceptibility to perforin-mediated lysis, and in some cases to
other pore forming molecules like SLO and melittin. This effort also examined whether
the endocytosis process was enhanced in the Gi/S target cells and in the CTLs. Finally,
experiments were initiated to determine whether other attributes of cells, like plasma




Cell lines were cultured in K-10 medium [K-10 medium: RPMI 1640-Hepes
modification (Sigma Chemicals) supplemented with 10% heat-inactivated fetal bovine
serum, (HyClone Laboratories) 50 pM p-mercaptoethanol, 2 mM glutamine, 100 U/ml
penicillin and 100 pg/ml streptomycin (Gibco Inc.)]. Murine tumor lines A20 (B-
lymphoma), P815 (mastocytoma) and YAC-1 (B-lymphoma) are described in the
Catalogue of Cell Lines and Hybridoma (American Type Culture Collection [ATCC];
Rockville, MD). The CTL line, BIID-3, is an L‘'-specific, allorective CTL cell line
derived from C57BL/6 mice. It was a gift from Dr. Mark Pasternack (Massachusetts
General Hospital). It was cultured in K-10 supplemented with 10 U/ml of recombinant
human IL-2 (a gift of the Amgen Corp.) and stimulated with irradiated (9,000 rads) A20
cells (1x10^ cells/ml).
CTLL-2, also described in the Catalogue ofCell Lines andHybridoma, was
derived from a cytolytic T lymphocyte line but has lost all cytolytic activity, although it
contains cytolytic granules and perforin. It was grown in K-10 medium supplemented
with 20 U/ml of rIL-2.
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They are Thl clones derived from ovalbumin stimulated BALB/C mice. The 5.5 and
5.9 cell lines were supplement with 10 U/ml rIL-250 pg/ml ovalbumin (Sigma Chemicals
Co.), and with irradiated (9000 rads) A20 cells (1x10^ cells/ml).
2.2 Cytolytic granules
Perforin containing gramdes were isolated from BIID-3 cells, as has been
described elsewhere [Verret, et al., 1987]. Briefly, lx 10^ cells were lysed by nitrogen
cavitation in Relaxation buffer (100 mM KCl, 3 mM NaCl, 3.5 mM MgCh, 1.25 mM
EGTA, 1 mM ATP, 10 mM PIPES, pH 6.8) for 15 minutes at 4°C at a pressure of 280
psi. Nuclei were removed by centrifugation at ~1000 x ^ for 5 minutes. The postnuclear
supernatant was layered atop a Percoll gradient (10 ml 90%; 5.5 ml 60%; 10 ml 39%;
Pharmacia). Gradients were subjected to centrifugation at 20,000 RPM in a Beckman
SW28 rotor {g^ = 58,000 g) for 30 minutes at 4°C. Fractions were collected and
assayed by hemolysis for perforin activity [Verret, et al., 1987]. Lytic fractions were
pooled, their density was augmented by addition of one half volume of 90% Percoll, and
Percoll particles were sedimented by centrifugation at 100,000 x g. The granules, which
sedimented as a fine layer above the Percoll, were resuspended in less than 1 ml of
Relaxation buffer and stored at -70°C.
2.3 CTLL-2 Lysate
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Cell pellets were washed and resuspended in sterile PBS containing ImM EDTA
at lx 10* cell/ml and lysed by freezing and thawing. One hundred microliter aliquots (lx
lO’ cells) were frozen and stored in microcentrifuge tubes at -70°C.
Cell suspensions were thawed rapidly and subjected to centrifugation for 10 minutes at
10,000 X g at 4°C. Perforin activity in the supernatant fluid was quantified by hemolysis
assay [Verret, et al., 1987].
2.4 Lvsis by Perforin Containing Granules/Lvsate. Streptolvsin-0 and Melittin.
A20 and P815 target cells (3 xlO^ cells) were arrested at the Gi/S interface by
culturing with 5 pg/ml aphidicolin or 2 mM thymidine for 24 hours at 37°C. Control
cells were incubated in parallel without the inhibitors. Cells were harvested and washed
to remove the inhibitors, then labeled with ^*Cr by incubation with 100 pCi ®‘Cr-sodium
chromate (NEN-Dupont) in 200 pi final volume for 1 hour at 37°C. Cells were washed
twice and incubated for 1 hour in K-10 medium to allow release of unbound ^*Cr.
Cells for perforin and melittin assays were transfered to lysis buffer by washing and
resuspending at 1 mM CaCb, 0.4 mg/ml BSA, pH 7.5; and in Ca^^-free PBS, pH 7.2, for
streptolysin-0 (SLO) assay. Labeled target cells (10'* cells in 100 pi) were added to 10 pi
of isolated granules, sterile CTLL-2 lysate, melittin or streptolysin-0 that were serially
diluted respectively in Relaxation buffers (see section 2.2) or 1 mM EDTA in PBS.
Maximum release of ^*Cr was determined from wells where cells were lysed with 10 pi
of 1% Triton X-100 (final concentration 0.1%). Minimum release was determined from
well receiving 10 pi of Relaxation buffer or PBS/EDTA. Plates were incubated at 37°C
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for 30 minutes and subjected to centrifugation (~1000 x g for 5 minutes). Radioactivity
of the supernatant fluid (30 pi) was determined by liquid scintillation counting. Percent
specific lysis was calculated as: 100 x [(cpm released in presence of granules or lysates) -
(minimum cpm released)] / [(maximum cpm released) - (minimum cpm relesed)]. No
significant lysis was observed when Ca^^ was omitted or chelated with EDTA, indicating
that lysis was dependent on perforin.
In some instances, cells surviving perforin-mediated lysis were isolated on
discontinuous Ficoll gradients. Briefly, 3 x 10^ A20 cells in 1 ml of lysis buffer (see
above) were incubated with 100 pi of isolated granules or CTLL-2 lysate for 15 minutes.
The mixture was layered atop 1 ml of Ficoll-Paque (Pharmacia) and subjected to
centrifugation at 1500 x g for 15 minutes at 4®C. Cells at the interface were carefully
removed by pipetting, washed in Hepes-buffered saline, and subjected to cell-cycle
analysis, as described in the flow cytometry section.
2.5 Lvsis by Intact CTLs
Tumor cells were labeled with ^‘Cr, as described above. Labeled target cells (lO'*
cell/well) and a varying number of BIlD-3 cells (1 x 10^-2 x 10^ cells) were combined in
200 pi of K-10 medium in microtiter wells and incubated for 4 hours at 37°C. After
centrifugation at 1000 x g, radioactivity released in 100 pi of supernatant fluid was
counted and percent specific lysis calculated as described previously. Maximum and
minimum lysis was determined respectfully, from wells containing 0.1% Triton X-100
and labeled target cells with no CTLs.
2.6 Fas-Mediated Apoptosis
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Fas-mediated apoptosis was triggered by cultiuing cells in K-10 medium with
Fas-specific monoclonal antibody Jo-2 (PharMingen). Cells (3x10* cells in 10 ml K-10
medium) were cultured with 2 mM thymidine or 5 pg/ml aphidicolin for 24 hours. Jo-2
was added to a final concentration of 12 ng/ml. Cells were incubated for another 24
hours prior to analysis. Viable, necrotic, and apoptotic cell were determined by flow
cytometry, as described below.
2.7 Flow Cytometry
Flow cytometry was performed on a FACSort equipped with argon-ion laser
(BDIS). For cell-cycle analysis, cells were fixed at 4°C with 70% ethanol for more than
2 hours, pelleted by centrifugation and resuspended in 1 ml of PBS containing 1 mg/ml
glucose, 1 mg/ml Rnase A (Sigma Chemicals), 50 pg/ml propidium iodide (PI) (Sigma
Chemicals). Flow cytometry was performed after 1 hour incubation on ice in PI. Ten
thousand events were recorded, stored and analyzed by ModFit-LT and Cell Quest
softwares (Becton Dickinson). Doublets were excluded with appropriate gates.
Apoptotic and necrotic cells were evaluated by incorporation of fluorescein
diacetate (FDA) and propidium iodide (PI) [Ross, et al., 1989]. Cells were washed and
incubated at 37°C for 10 minutes with 5 pg/ml FDA and 10 pg/ml PI in 4.5 ml ofK-10
medium. Viable cells incorporate FDA but exclude PI. Apoptotic cells exclude both
fluorophores. Necrotic cells incorporate PI while excluding FDA. Data were analyzed
using Cell Quest software.
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2.7.1 Sorting ofCytotoxic T-Lvmphocvtes fCTLsl from their Tareet/CTL Conjugates
CTLs were isolated from antigen presenting cells by flow cytometry at different
times after antigen stimulation. CTLs that had not been stimulated with antigen
presenting cells for 5-7 days were incubated with an equal amount (2 x 10^) of irradiated
A20 cells. CTLs and target A20 cells were incubated at 37°C, 5% CO2 at several time
points including 1, 2, 4, 7, 16, 24,48 and 72 hours. Cultures were harvest and incubated
for 5 minutes with EDTA at a final concentration of 5 mM. The cultures were centrifuge
for 5 minutes at 1,000 rpm. The supernatant of each culture was discarding and the pellet
(cells) was resuspended in 0.25 ml ofK-10 medium. To disrupt conjugates of T cells and
targets, the cell mixture was vortexed. After the vortexing a final concentration of 0.02%
NaN3 was added to the 0.25 ml of cell mixture. Two specific monoclonal antibodies
were added to the mixture to distinguish target from effector cells by flow cytometry. To
identify the target cells (A20 cells) was added 2.5 pg/ml of an anti-MHC 1 H-2D‘’-FITC
antibody (PharMingen). To identify the effector cells (CTLs) it was added 2.5 pg/ml of
an anti-CD8 H-2D*’-PE antibody (PharMingen). The sample was placed on ice, covered,
and incubated for one hour. After incubation, samples were centrifuged for 5 minutes at
1,000 rpm and washed twice with cold lx PBS. Then the cells were resuspended in 0.5
ml of lx PBS for flow cytometry analysis and further sorting (Figiue 2.1).
Cells that fluoresce red, the CTLs, were selected and sorted for cell cycle analysis. This
experiment showed that, is possible to separate conjugates of target/effector cells by
vortex, identify them with monoclonal antibodies, and moreover sort CTLs at different
times of their proliferation or cell cycle.
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As an alternative method, after the vortex step 0.25 ml of 0.02% NaNa and 2.5
pg/ml of FC block antibody, was added to the cell mixture, then the mixture was
incubated for 10 minutes on ice. Later, 2.5 pg/ml of the anti-CD8 H-2D'’-FITC antibody
was added to the sample and incubated on ice for one hour. After the incubation the cells
were centrifuged and washed twice with cold lx PBS buffer, then resuspended in 0.5 ml
of lx PBS buffer for flow cytometry analysis and sorting. Cells that fluoresce green are
the CTLs and the unstained, the target cells. CTLs were selected and sorted for cell cycle
analysis (Figure 2.1).
The next step in the experiment was to isolate, by flow cytometry sorting, CTLs
in a specific stage of their proliferation or cell cycle, to conduct susceptibility experiment
studies. For this type of experiments another type of immunofluoresence labeling was
used. This time, after vortex step, 0.02% NaNs and 2.5 pg/ml of the anti-H-2D‘‘-FITC
antibody, was added to the 0.25 ml of cell mixture. This antibody binds to the target cells
only. In this experiment the CTLs will remain unlabelled, and the imlabelled population
was the one sorted (Figure 2.1).
2.7.2 Sorting
The killing assays required at least 1x10^ cells to start, because during the process
cells are lost. Each time that was necessary to sort cells for killing assays the sorting was
done 10 times at flow rate of 300 cells/second, 100,000 cells were sorted each time.
After sorting, each tube was centrifuged 10 minutes at 950 rpm, the supernatant was
aspirated leaving the last 5 ml in each tube.
Separation ofCytotoxic T-Lymphocytes (CTLs) from their target/CTL Conjugates
Purpose: To isolate CTLs atAfferent stages ofthe cell cycle; and then check their susceptibility toperftnin-lysis
2x10^ CTL>Bin>>3 + ZxlO’Jrnidiated A20 + 10 u/ml IL-2
incubate fotj 1,2,4,7,16,24,48,72,96 hours
Harvest, Centrifuge and Resuspend in 0.25 ml ofK-10 medium
*«|1
Vortex for 35 seconds
Add 0.02% NaNj
Add anti -MUC 1 H-2D‘‘ FTTC (target) +
anti-CD8 H-2D'’ PE Effector)
jlncubate 1 hour on ice
Wash 3xwith cold lx PBS
Flow Cytometry/Cell Sorting
The cells that fluoresce red
Sorted CTLs are use to check the technique
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|lncubate 10 minutes on ice
Add anti-CD8 H-2D'’ FITC
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Hie cells that|luoresce in green
SortedCTLs are use to check the CellCycle Stage
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Each remaining 5 ml were transfered to one tube and centrifuged again; supernatant
was discarded and the pellet (the sorted CTLs) was resuspended in 0.2 ml of K-10 and
used for the assay. The same procedure was used for cell cycle analysis, but with the
difference that the pellet was resuspended directly in 70% ethanol 200 proof and stored
overnight at 4°C.
2.8 Endocvtosis Experiments
In order to check if the endocytosis process was enhanced in A20 and P815 Gi/S
cells, we monitored the cells for uptake of FITC conjugate Dextran and endocytosis
tracer. Targets cell cycles were blocked and incubated the cells with 5 pg/ml aphidicolin
or 2 mM thymidine for 24 hours. After been harvested and washed with cold lx PBS pH
7.0, they were incubated for 1.5 hours with 1 mg/ml FITC-dextran (MW 10,000) (FD-10)
(Sigma Chemical), at 37°C. After the incubation, cells were centrifuge and washed twice
with 1 ml of cold IX PBS, pH 7.0. Samples were immediately analyzed by flow
cytometry.
To investigate active ATP-dependence process of endocytosis, main cell sources
ofATP were depleted. Target cells were pre-incubated for 2 hours at 37°C in media with
1 mM KCN, 1.5 mM NaN3, inhibitors of oxidative phosphorylation and with 2-
deoxyglucose (5 mM), an inhibitor of glycolisis. All samples, including control cells
were washed twice with cold IX PBS and resuspended in 1 ml of 1 mg/ml of FD-10 in
PBS; in addition 1 mM KCN, 1.5 mM NaN3 and 5 mM 2-deoxyglucose were included
for cells that had been pre-incubated with these inhibitors [Verret, et al, 1987]. In some
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experiments T-cell lines 5.5, 5.9 and CTLL-2 were incubated in parallel without the
inhibitors.
After the incubation, cells were centrifuged and washed twice with 1 ml of cold IX PBS,
pH 7.0. Samples were immediately analyzed by flow cytometry
Also, to check if our system was temperature dependent, the cells were incubated
with FD-10, at 0, 15, 25 and 37 degrees C. In some experiments, it was checked how
some cells recovered after the FD-10 incubation. Cells were incubated with FD-10 for
1.5 hours at 37°C, and then after been washed twice, the cell pellet was resuspend in fresh
media. After 3 hours in fresh media, endocytosis levels within the cells were detected by
flow cytometry.
2.9 Purification and Analysis ofGaneliosides
The low concentration of gangliosides and small size of available samples can
present difficulties for their purification and analysis [Ladisch, S., and Li, R., 2000]. This
has been approached in several ways. In one case, gangliosides shed by tumor cells when
the culture starts growing to a medium-high density were harvested [Chang, F., et al,
1997]. Quantification of gangliosides requires good recovery and a sensitive detection
method. To satisfy these requirements, the three-step purification method for microscale
isolation and purification of gangliosides from the total lipid extract of cultured cells was
used [Ladisch, S., and Li, R., 2000; Ladisch, S., and Gillard, B., 1987 and 1985].
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2.9.1 Three-Step Purification Method
The three-step purification method consists of (1) preparation of dry total lipid
extract, (2) partition of the total lipid extract in diisopropyl ether (DIPE)/1-
butanol/aqueous NaCl (DIPE/butanol partition), and (3) Sephadex G-50 gel filtration.
This total lipid extraction reduces the high concentration of proteins and salt relative to
gangliosides. The solvent partition step separates gangliosides from most other lipids.
Finally, the lower aqueous (ganglioside-containing) phase from this solvent partition is
purified by gel filtration to remove low molecular weight contaminants (salt and
peptides). The final total ganglioside preparation is dried and stored in dry state (Figure
2.2).
2.9.2 Total Lipid Extraction
One average 6 x lO’ cells were harvested for each Total Lipid Extraction (TLE).
The cell pellet was resuspended in chloroform: methanol (1:1, v/v; 10 ml) in a Branson
bath sonicator to disperse the solid material. The samples are extracted for 18 hours at
4®C with a magnetic stirring, and then centrifuged at 2000 rpm for 10 minutes. The clear
supernatant was transferred to a 15 ml glass centrifuge tube. The extract was reduced to
about one-quarter of the original total volume by evaporation under a stream of nitrogen
and then cooled for 2 hours at -70°C. This served to further precipitation of salts and
other polar molecules such as glycoproteins that are partially soluble in
chloroform/methanol, without loss of gangliosides. After centrifugation, the clear
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ganglioside-containing supernatant was transferred to a 15 ml glass centrifuge tube for
partition. But first, the supernatant was completely dried xmder a stream of nitrogen.
2.9.3 DIPE/Butanol Partition
The organic phase, 10 ml of (DIPE/1-butanol, 6:4, v/v) was added to the dried
total lipid extract. The sample was vortexed and sonicated to achieve a fine suspension
of the lipid extract. Then, the aqueoxis phase was added, 5 ml of 50 mM aqueous NaCl.
The ratio of organic phase to aqueous is 2:1 (v/v). After the addition of the aqueous
phase the sample was alternately vortexed and sonicated for 2 min, and then centrifuged
at 2000 rpm for 10 min. The upper organic phase, which contains neutral lipids and
phospholipids, was carefully removed using a Pasteur pipette, and the lower aqueous
(ganglioside-containing) phase was repartitioned with the same volume of fresh
DIPE/1 butanol (6:4, v/v). The sample was alternately vortexed and sonicated for 2 min
and centrifuge as above. The residual organic solvents were removed by stream of
nitrogen gas from the final aqueous phase. Also was important that the samples were
completely dry prior to gel filtration.
2.9.4 Senhadex G-50 Filtration
The dried samples were redissolved with 0.3 ml of ddHaO, and were sonicated to
ensure micelle formation and then loaded onto a Sephadex G-50 column which had been
equilibrated in ddH20. Then a column which bed volume was 10-15 ml; inside diameter,
8 mm and flow rate about 0.25 ml/min, was used to filter the samples. Samples were
eluted with ddH20, and were collected in 1 ml (20 drops) fractions using a fractionator;
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later each fraction was monitored using the spectrophotometer at 206 nm. The
gangliosides were eluted in the void volume peak which is between 5-7 ml.
2.9.5 Thin Laver Chromatography and Chemical Detection ofGangliosides
Because of their amphipathic character, glycosphingolipids can be analyzed by
thin layer chromatography (TLC), which is useful for monitoring purification, for
qualitative and quantitative determination of gangliosides. TLC was performed on LHP-
K preadsorbent silica gel 60 High-Performance TLC (HPTLC), glass support plates,
(layer thickness of 200 pm) from Whatman. In the experiments 10 xlO cm HPTLC
plates (dimensions) were used. The HPTLC plates were activated by placing them in an
oven at 125°C for 1 hour. The samples were applied (5 pi), to the preadsorbent area of
plate and dried using a forced air dryer. Then the plate was transfer to the
chromatography tank, for the developing step. TLC solvent mixture was added to the
tank to a depth of ~0.5 cm at least 30 minutes prior to initiating chromatography. Tanks
were covered with glass lids. The most widely used TLC developing solvents for
glycosphingolipids in general are mixtures of chloroform-methanol and aqueous salts
(0.25% CaCb) For gangliosides separation the solvent system was chloroform-methanol-
aqueous salt (60:40:9 v/v) (Figure 2.2). Divalent salts alter gangliosides mobility and
improve their resolution. After running, the plate was removed and solvents were
allowed to evaporate in a fume hood. The drying step was accelerated by mild heating in
an oven at 100®C for 10 minutes. Next, the dried plate was sprayed in a fume hood with
Resocinol-HCl reagent, using a fine mist sprayer (10 ml, Kontes, Vineland, NJ) in a
zigzag pattern until the plate surface was covered. Resorcinol-HCl-Cu^^ reagents based
on L. Svennerholm, 1957, remain one of the most selective and sensitive tools for
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ganglioside detection on TLC plates [Schnaar, R.L., and Needham, L.K., 1994;
Ladisch, S., and Li, R., 2000].
Resorcinol-HCl-Cu^"^ spray reagent was prepared by mixing 20 ml of 1.5%
aqueous resorcinol, 0.3 ml of 1% (w/v) aqueous cupric sulfate pentahydrate, 30 ml of
concentrated aqueous HCl, and 50 ml of water. The dried chromatograph was sprayed
moderately with the reagent. Then it was covered with a clean glass plate, which was
clipped with binder clips, and placed in an oven at 125°C for 30 minutes. Gangliosides
appeared blue-violet against the white background, whereas neutral and sulfated
glycosphingolipids appear yellow brown (Figure 2.2).
2.10 Metabolic Radiolabeling ofCellular Gangliosides
Metabolic radiolabeling permits sensitive detection of newly synthesized
gangliosides. This approach can be applied to detection of both cellular gangliosides and
gangliosides shed in vitro in experimental systems [Ladisch, S., and Li, R., 2000; Li, R.,
and Ladisch, S., 1997]. In our system, it was used only to detect cellular gangliosides.
The cell lines, A20, P815, YAC-1, and CTLL-2 were cultured at a density of 3-5
xlO^ cells/ml in 10 ml medium in T-75-cm^ flask. After overnight incubation, the cells
were metabolically radiolabeled for 24 hours with 1 pCi each of D-[6-^H] galactose
(specific activity, 29.5 Ci/mmol) and D-[6-^H] glucosamine hydrochloride (specific
activity, 20.3 Ci/mmol) per milliliter of culture medium, to enhance the specific activity
of the radiolabeled gangliosides (Figure 2.2). The radiolabeled cells were harvested,
centrifuge at 1000 rpm for 5 minutes. Supernatant was discarded and cell pellet was
wash 3 times with PBS prior to processing for ganglioside purification. Ganglioside
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purification was performed as described in the previous section. Briefiy, the total lipids
of cells were isolated by chloroform/methanol extraction, as described above, and
gangliosides were purified by diisopropyl ether/1-butanol partition follow by Sephadex
G-50 gel filtration (Figure 2.2) [Li, R., and Ladisch, S., 1997].
The purified gangliosides were detected by HPTLC autoradiography. Purified
radiolabeled gangliosides were spotted on silica gel HPTLC plates. The plates were
developed in chloroform/methanol/0.25% aqueous CaCl2 (60:40:9, v/v/v) to separate
gangliosides. The radiolabeled gangliosides were revealed by exposure of XRP X-ray
film to the plates for 2 weeks.
Isolation ofgaogliosides from tissue culture murine cell lines
Latisch, S. tuHl GUkml, A (J9SS) AnatyOcedBioehmisny;Methods in Enjymology (1987)
Plate 3x10* ceUsAml ta 29 ml
Metabolic labeling of ganglioskies
(2 T150 flasks)
Incnbate for 24 boors
with 3H galactose& 3B glusosamine
Regoiar Isolatioii of ganglioskies
/
(4T150flask)
Extractkui for 18 hrs at 4*’C with 1:1 chkarolioriW OMtbanol
Partitioning of completely dry Total LipM Extract (TLE)
With Smls (6:4) DIPE/l-Butanol & 2.5 mis of0.1% NaCl
Upp« esrganic pbaae is removed, and lower phase is completely dried
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SMix>les lie ehiied wMiddHiO, (nctionaied and dried in speed rotor
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3.1 Susceptibility of Cells to T-Cell Mediated Cvtolvsis is Dependent on the Cell-Cvcle
Cells cultured in the presence of thymidine or aphidicolin undergo proliferative
arrest. Based on cell proliferation assays shown in DeLeon, et al., 1998; the lowest
concentrations of thymidine (2 mM) and aphidicolin (5 pg/ml) that arrested proliferation
were selected. Cells arrested at these concentrations for 24 hours were analyzed by flow
cytometry for cell-cycle profiles. Figure 3.1 shows that A20 and P815 cells were arrested
predominantly in the Gj phase of the cell cycle at these concentrations of thymidine and
aphidicolin. Profiles of A20 and P815 cells blocked with either thymidine or aphidicolin
indicate a reduction of S-phase cells and near abolition of G2-phase cells (Table 1).
Subsequently, the treated A20 and P815 cells were incubated either with CTL cytotoxic
granules or the Fas- monoclonal antibody Jo-2.
To determine whether cells arrested in Gi differed from cycling populations in
sensitivity to perforin, cells were arrested in Gi either with thymidine or aphidicolin,
labeled with ^^Cr-sodium chromate, and subjected to lysis with CTL cytotoxic granules
as described in Materials and Methods. In these experiments, cells arrested in Gi,
whether with aphidicolin or thymidine, were lysed less efficiently than cycling controls
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mediated lysis, was omitted or with addition ofEDTA (DeLeon, M, 1998 MS Thesis).
Background lysis of thymidine or aphidicolin-blocked cells was less than 7% and did not
differ significantly from that of cycling controls.
Figure 3.1 Cell-Cvcle Profiles ofCells Cultured in 2 mM Thymidine or
5 ug/ml Aphidicolin.
(a) Cell-cycle profiles of a freely cycling population of A20 cells were compared to
profiles of cells arrested with (b) thymidine or with (c) aphidicolin. Also, (d) freely
cycling P815 cells were compared to P815 arrested with (e) thymidine or with (f)
aphidicolin. Cells were cultured in thymidine or aphidicolin for 24 hours, and their cell-
cycle profiles were evaluated by flow cytometry as described in Materials and Methods.
The abscissa is arbitrary units of DNA content and the ordinate represent cell number.
Percentage of cells on the three phases of cell cycle were presented in Table 1.
Table 1. Cell-Cycle Profile of Cells Cultured in 2 mM Thymidine or
5 ng/ml Aphidicolin
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controls thymidine aphidicolin controls thymidine aphidicolin
G, 37.9 ± 2.3 65.9 ± 5.9 74.2 ± 10.6 37.6 ±1.1 77.6 ±1.1 63.6 ±3.9
S 50.2 ± 2.9 34.0 ± 5.7 23.1 ± 7.7 51.3 ±1.3 22.0 ±3.7 32.8 ±10.1
02 11.9± 1.0 0.1 ± 0.2 2.4 ± 4.2 11.2± 0.4 0.4 ± 0.3 4.2 ± 7.0
P815 and A20 cell lines expressed high levels of Fas on their surfaces, as judged
by flow cytometry of cells stained with fluoresceinated Jo-2 (DeLeon, 1998, MS Thesis).
Cells were triggered to undergo apoptosis by culture with 12 ng/ml of the monoclonal
antibody Jo-2 (DeLeon, et al., 1998). P815 and A20 cells arrested with thymidine or
aphidicolin were more sensitive to Fas-mediated apoptosis than were cycling cultures
(Figure 3.2). As shown, the percentage of apoptotic cells increased markedly among
cells blocked at the Gi/S interface, either with thymidine or aphidicolin. This effect
contrasts with the reduced susceptibility to granule-mediated lysis shown in figure 3.3.
Apoptosis was identified by flow cytometry as cells that did not incorporate significant PI
and FDA.
The results presented in figures 3.2 and 3.3 shows that growth arrest of target cells
alters their sensitivity to granule-mediated lysis and Fas-triggered apoptosis. These
observations suggest that sensitivity to CTL-mediated cytotoxicity may also be affected
by growth arrest. Susceptibility of cells arrested in Gi to lysis by intact CTLs was
evaluated in 4 hour chromium-release assays. As figure 3.4 shows, susceptibility to lysis
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by intact CTLs was not affected significantly by blockade of target cells with
aphidicolin or thymidine. Lysis by intact CTLs involves recognition of surface antigen,
activation of CTLs and delivery of cytotoxic factors. Thus, multiple factors may be
involved in explaining the stark contrast between the responses to killing by isolated
granules and Jo-2 and to cytolysis by intact CTLs.
This laboratory has demonstrated that cells arrested in Gi were less susceptible to
perforin. To eliminate the possibility that a drug-induced artifact underlies these
observations, an alternative approach was imdertaken that was independent of thymidine
and aphidicolin. Cells were lysed with perforin-containing granules and survivors were
isolated on Ficoll gradients (DeLeon, et al., 1998). Distributions within the cell cycle
were examined by flow cytometry. When compared to controls incubated in parallel with
buffer lacking granules, survivors from cells incubated with granules were enriched in Gi
phase cells and contained significantly fewer Gi cells (Figure 3.5; Table 2). Enrichment
of Gi cells was also observed when A20 cells were incubated with lysates of CTLL-2
with Ca'''^. Gi phase cells died less readily in cycling populations than other cells. These
observations are consistent with the observed resistance to perforin of cells arrested with
thymidine or aphidicolin. The data suggest that cells in Gi phase of the cell cycle are less
susceptible to the perforin pathway than cells in G2 and S phases.




A20 (open bars) and P815 (filled bars) cells were arrested in 2 mM thymidine (thvi or 5
pg/ml aphidicolin (aohi. then cultured with a fas-specific monoclonal antibody (Jo-2).
Cells were evaluated by flow cytometry as described in Materials andMethods. Percent
ofapoptotic nuclei were determined from the analysis of 10,000 events.
Figure 3.3 Granule-Mediated Lvsis of Cells Arrested in Gi
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Relative Granule concentration Relative Granule concentration
A20 (a, b) and P815 (c,d) cells were cultured in 2 mM thymidine or 5 (ig/ml aphidicolin.
Lysis of the cells by isolated CTL granules was evaluated as described in Materials and
Methods. The ordinate (% specific lysis) represent the mean ± SD of triplicate
measurements. Closed circles (•) represent lysis of thymidine-blocked A20 or P815, and
close squares (■) represent lysis of aphidicolin-blocked A20 or P815. Open circles (O)
represent lysis of control A20 or P815, not blocked with inhibitors.
Figure 3.4 Lvsis bv Intact CTLs ofA20 and P815 Cells Arrested in Gi.
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EffectonTarget cells ratio (E:T) EffectorTarget cells ratio (E:T)
A20 (a, b) and P815 (c,d) cells were cultured in 2 mM thymidine or 5 [ig /ml aphidicolin.
Target cells were incubated with varying numbers of CTLs (BIID3) and the extent of
lysis was determined as described in Materials and Methods. The ordinate (% specific
lysis) represent the mean ± SD of triplicate wells. Closed circles (•) represent lysis of
thymidine-blocked A20 or P815, and close (■) squares represent lysis of aphidicolin-
blocked A20 or P815. Open circles (O) represent lysis of control A20 or P815, not
blocked with inhibitors.
Figure 3.5 Cell-Cvcle Profiles ofPerforin - A2Q Survivor Cells.
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A20 cells were incubated with lysis buffer without granules (panel A) or with CTL
granules (panel B) and survivors were separated on Ficoll gradients, as described in
Materials and Methods. Cell-cycle profiles of survivors were determined by flow
cytometry and quantified using Modfit LT software, as described in Materials and
Methods. Percentage of cells the three phases of the cell cycle were presented in Table 2.
Table 2. Cell-Cycle Profile ofA20 Cells Surviving Exposure to CTL Granules.
Percentage of cells ± SD (n=7)
Phase of











3.2 Susceptibility ofGi/S Target Cells and CTLs to Streptolvsin-0 or Melittin Lvsis
To test whether Gi/S murine target cells and CTLs are susceptible to other pore-
forming proteins as well, cell lysis by streptolysin-0 and melittin was determined.
Streptolysin-0 (SLO), a 69-kDa protein secreted by most strains of the Lancerfield group
A P-hemolytic Streptococci, is know to perforate cell membranes by formation of
polymeric tubular channels, similar to perforin [Muller and Tschopp, 1994: Bhakdi, S.,
and J. Tramun Jensen 1987]. Melittin is a cytolytic polypeptide (6-26 amino acids)
derived from bee venom. The ways in which melittin binds to membranes and the
mechanism(s) by which it disrupts the bilayers are not know with certainty. It apparently
destabilizes the bilayer very quickly forming ion channels which enhance permeability,
bursting the cell membrane by osmotic lysis [Katsu, et al., 1989; Verret, et al., 1987]. As
shown in figure 3.6a and c, A20 and P815 Gi/S blocked cells are less susceptible to SLO-
mediated lysis.
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Figure 3.6 Streptolvsin-0 and Melittin-Mediated Lvsis ofCells Arrested in G^.
0 1000 2000 3000 4000 6000 6000
Strcptolysiii-O (U/ml)
Mdittia (iif/mO
A20 (a, b) and P815 (c, d) cells were cultured in 2 mM thymidine or 5 ng/ml aphidicolin.
Lysis of the cells by SLO or Melittin was evaluated as described in Materials and
Methods. The ordinate (% specific lysis) represent the mean ± SD of triplicate
measurements. Open circles (O) represent lysis ofaphidicolin-blocked A20 or P815, and
open squares (□) represent lysis of thymidine-blocked A20 or P815. Filled circles (•)
represent lysis of control A20 or P815, not blocked with inhibitors.
Figure 3.7 Susceptibility ofCTLs to Streptolvsin-0 (SLO') and Melittin Lvsis.
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Lysis ofthe CTLs by SLO (7a) orMelittin (7b) was evaluated as described in Materials
andMethods. The ordinate (% specific lysis) represent the mean ± SD of triplicate
measurements. Open circles (O) represent lysis ofBIID-3 CTL cell line, and open
squares (□) represent lysis of2C CTL cell line. Filled circles (•) represent lysis of
control A20 tumor target cell line.
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However they do not differ in susceptibility to melittin lysis (Figure 3.6b and d). Also
was observed, as shovra in figure 3.7, that the perforin-resistant CTL cell line BIID-3 is
also resistant to SLO-mediated lysis (Figure 3.7a), but like its tumor target, is lysed by
melittin (Figure 3.7b). These data demonstrate the specificity of the resistance
mechanism for large pore-formers such as SLO; rather than small membrane-perturbing
polypeptides, like melittin.
3.3 Susceptibility ofCTLs to T-Cell Mediated Cvtolvsis is Not Dependent on the
Cell-Cvcle
To check if the proliferative status ofCTLs during target cell attack is important
to their survival, we isolate by flow cytometry cell sorting, as described inMaterials and
Methods, CTLs (BIID-3) at different points of their cell cycle (Figures 3.8 and 3.9).
BIID-3 doubling time is close to 48 hours. Usually, after 96 hours of target cell
exposure, the BIID-3 cells have cleared all target cells and are ready to use for
experiments. At time 0, BIID-3 CTLs, start to encoimter the irradiated A20 target cells in
presence of IL-2. These CTLs which have not been stimulated with antigen presenting
cells for 7 days are in the Gi phase of the cell cycle, and remain in this stage for 16 hours
(Figure 3.8). At 16 hours, CTLs have received the activation signal and begin to cross
Gi/S interface of the cell cycle. At 24 hours, most of the population has transitioned the
Gi/S phase of the cell cycle, and at 48 and 72 hours as figure 3.9 shows, a BIID-3
proliferating population is established. Microscopic observations and cell viability
determination by trypan blue exclusion indicated that target cells were getting cleared
from the CTLitarget cell culture. CTLs cell sorting served to confirm that, 72 hours after
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target cell encounter, more than 75% of the target cells were cleared from the
CTL:target cell culture. By 96 hours the population was purely BIID-3 CTLs, ready for
experiments and devoid of target cells. Figure 3.10 represents the cell cycle distribution
of the CTL-BIID-3, after target cell encounter. Most of the cells remain in Gi phase in
the first hours, getting ready for cell division, but between the 24 and 72 hours an
aggressive proliferation takes place leading to clearance of the target cells. Cell sorting
successfully separated CTLs from their target cell conjugate (recovery > 87% pure).
Figure 3.8 Cell-Cycle Profiles ofCTL-BIID-3 at Different Points of the Cell-Cvcle. (D
2hr 4hr
Cell-cycle profiles were evaluated by flow cytometry as described in Materials and
Methods. The abscissa is arbitrary units ofDNA content and the ordinate represent cell
number.
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Figure 3.9 Cell-Cvcle Profiles ofCTL-BIID-3 at Different Points of the Cell-Cycle. (11')
24hr 48hr
Cell-cycle profiles were evaluated by flow cytometry as described in Materials and
Methods. The abscissa is arbitrary units ofDNA content and the ordinate represent cell
number.
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We examined the susceptibility of these BIID-3 cells to perforin mediated-lysis
at different stages of the cell cycle. Figure 3.11 indicates that at all stages ofthe cell
cycle the CTL-BIID-3 remain resistant to perforin-mediated lysis in comparison to the
controls, A20 target cell and normal cycling BIID-3 cells.
Figure 3.10 Cell-Cvcle Distribution of the CTL-BnD-3.
Percent ofBIID-3 cells at Gi phase (open bars), at S phase (stripe filled bars), and at
Ga/M (triangle filled bars). Cells were evaluated by flow cytometry as described in
Materials andMethods. The abscissa is hours and the ordinate is percentage ofBIID-3
cells at each phase ofthe cell cycle.
Figxire 3.11 Granule-Mediated Lvsis ofBIID-3 Cells at Different
Points ofProliferation.
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BIID-3 cells at different points ofproliferation were isolated by cell sorting. Lysis of the
cells by perforin containing granules was evaluated as described in Materials and
Methods. The ordinate (% specific lysis) represent the mean ± SD of triplicate
measurements. Open circles (O) represent lysis ofBIID-3 control cells, and open
squares (□) represent lysis ofBIID-3 isolated at different points ofproliferation. Filled
circles (•) represent lysis of control A20 target cells.
3.4 Membrane Repair bv Enhanced Endocvtosis
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The data presented in sections 3.2 and 3.3 indicate that CTLs as well Gi/S cells
resist perforin and SLO lysis. The reason may be that they can repair more efficiently the
pore lesions in the membrane via endocytosis and restoration of ionic gradients. To
address this hypothesis, flow cytometric experiments were carried out incubating the A20
and P815 tumor Gi/S cells and other lymphoid cells, as controls, with the endocytosis
tracer FITC-dextran (FD-10), as described in Materials andMethods.
Endocytosis is a temperature- and ATP-dependent process, as figures 3.12 and
3.13 show. A20 and P815 cells were incubated with FD-10 tracer at different
temperatures. At 37®C (Figure 3.12), cells incorporated by endocytosis ten times more
FD-10 than at 0°C, because all cell metabolic functions are reduced due to the cold
temperature and membrane reorganization prevented. Figure 3.13 shows the endocytosis
levels ofFD-10 in the A20 and P815 cells after been treated with the ATP depleting
agents, KCN, NaNa, and 2-deoxyglucose, as described in Materials andMethods. In
comparison to the controls in both cell lines, we observed poor incorporation ofFD-10
into the cells by endocytosis. P815 and A20 cells, arrested at the Gi/S interface of the
cell cycle, as figure 3.14 shows, manifested enhanced endocytosis. A20 arrested cells
with aphidicolin or thymidine incorporated FD-10 four times more than the control and
the Gi/S P815 cells two times more than the control. This implies that endocytic
clearance of lesions may explain the decreased in susceptibility ofGi/S blocked cells.






The endocytosis levels on the target cell lines A20 (top) and P815 (below) were
determined by flow cytometry. Target cells were incubated with (blue and red) or absent
(filled green) the endocytosis tracer FITC-dextran (1mg/ml) for 1.5 hours; at 0°C degrees
(blue) and at 37”C (red) as described'mMaterials andMethods. Vertical and horizontal
axes represent the cell number and relative logarithmic fluorescent intensity, respectively.
Figure 3.13 ATP Dependence of the Endocvtosis Process.
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The endocytosis levels on the target cell lines P815 (top) and A20 (below) were
determined by flow cytometry. Target cells were pre-incubated with the ATP depleting
reagents KCN, NaNs and 2-deoxyglucose (red) parallel with the controls (green) for 1.5
hours. After being harvested and washed target cells were incubated with (green and red)
or absent (filled green) the endocytosis tracer FITC-dextran (1mg/ml) for 1.5 hours; at
37°C degrees, as described \r\Materials andMethods. Vertical and horizontal axes
represent the cell number and relative logarithmic fluorescent intensity, respectively.
Figure 3.14 Levels ofEndocytosis in Gi^/S Blocked Murine Target Cells.
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The endocytosis levels on the target cell lines A20 (top) and P815 (below) were
determined by flow cytometry. Target cells were incubated with 5 (ig/ml aphidicolin
(red) or 2 mM thymidine (blue) parallel with controls (green) for 24 hours. After been
harvested and washed, target cells were incubated with (green, blue and red) or absent
(filled green) the endocytosis tracer FITC-dextran (1mg/ml) for 1.5 hours; at 37*^0
degrees, as described'mMaterials andMethods. Vertical and horizontal axes represent
the cell number and relative logarithmic fluorescent intensity, respectively.
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To check if endocytic clearance ofpore lesions may contribute with the resistance of
CTLs, we compared the CTL cell lines CTLL-2 with two CD4 T cells, 5.5 and 5.9, and
also with the tumor cell line A20 as a control. Figure 3.15 shows an enhancement in
membrane endocytosis in all the T cell lines in comparison to the A20 control. But no
significant difference was observed between the modest perforin-resistant CD4 cell lines
and the perforin-resistant CTLL-2 cell line.
Figure 3.15 Levels ofEndocytosis in Different Types ofMurine Lymphoid Cells.
A20 cells
S.5 CD4 T cells
5.9 CD4 T cells
CTLL-2 CDS T cells
The endocytosis levels on the cell lines A20 (filled green), 5.5 (red), 5.9 (blue) and
CTLL-2 (green) were determined by flow cytometry. Cells were incubated with the
endocytosis tracer FITC-dextran (Img/ml) for 1.5 hours at 37”C degrees as described in
Materials andMethods. Vertical and horizontal axes represent the cell number and
relative logarithmic fluorescent intensity, respectively.
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3.5 Isolation and Preliminary Analysis ofGaneliosides.
CTLs and murine tumor cells blocked at the Gi/S phase of the cell cycle are less
susceptible to getting killed by perforin and streptolysin-0 mediated lysis. CTLs are
highly resistant to perforin; therefore they survive exposure to their own secreted
perforin. Studies suggest that components ofCTLs membranes interfere with the
insertion ofperforin and formation of transmembrane channels [Verret, et al., 1987;
Jiang, et al., 1988; Shinkay, et al., 1988; Jones and Morgan, 1991]. Other laboratories
have indirect data supporting a self-protection mechanism against perforin-mediated
cytolysis by killer cell-specific surface protein(s), probably glycolsylated [Jiang, et al.,
1990, Liu, et al., 1995]. Lipids influence membrane fluidity ofcell plasma membrane.
Plasma membrane lipid content also could be related to the endocytosis process of the
cell. Lipids may specifically interact with perforin. Therefore, this laboratory decided to
check the lipid content in murine cells, and for now, one type ofplasma membrane lipids
was studied, the gangliosides.
Purified gangliosides were isolated from A20, P815, YAC-1 and CTLL-2 cells,
and analyzed by HPTLC as described in Materials andMethods. A ganglioside mixture
from Sigma Chemicals was used for standards. HPTLC analyses were performed using
other gangliosides standards from Sigma, to verify the standard mixture composition. As
figure 3.16 shows, the ganglioside mixture contains four gangliosides, GMl (6.7%),
GDla (49.5%) and GTlb (35%). The identity of the fourth standard agrees with the
migration ofpurified and characterized GDlb. The ganglioside GM3 is not in the
ganglioside mixture. HPTLC analysis of the YAC-1 gangliosides migration pattern
(Figure 3.17) revealed a complex ganglioside composition. However, one of the major
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gangliosides synthesized by YAC-1 cells is GMlb (~ 20.6%). It migrated with HPTLC
mobility between the gangliosides standards GMl, GDla as a doublet [Mckallip, et al.,
1999].
Figure 3.16 HPTLC Chromatograph ofGangliosides Standard Mixture.
Gangliosides were visualized as purple bands on the HPTLC plate with resorcinol-HCl
reagent. Ganglioside mixture was included in one lane of each plate as internal control.
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Figure 3.17 HPTLC Chromatograph ofGaneliosides from YAC-1 Cell Line.
Total cellular gangliosides were isolated and purified from YAC-1 tumor cells. YAC-1
gangliosides elute in fractions 3-7. The HPTLC plate was develop in CHCl3;CH30H:
0.25% CaCl2 (60:40:9, v/v/v) to separate gangliosides. Gangliosides were visualized as
purple bands on the HPTLC plate with resorcinol-HCl reagent. The yellow spots are
impurities or small amounts of neutral and sulfated glycosphingolipids.
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A20 and P815 cells (Figure 3.18) contain lower levels of gangliosides species
compared to YAC-1 cells. In A20, three types of gangliosides were identified GMl
(83.2%), GDla (7.9%) and an unknownwith (8.9%), which could be GDlb (Figure 3.18,
above fraction 3-4). A20 fractions 5-6 have the same ganglioside pattern described
above. Therefore we combined the fractions. However, A20 fractions 7-8 and 9 were
determined to be impurities, due to the yellow-brown color.
In P815 cells (Figure 3.18, below fraction 4-5), three types of gangliosides also
were identified, but the HPTLC patterns differ from the A20 gangliosides. It was
identified as GMl (76.5%) and GDla (7.1%) and a doublet (51.5%), like in the YAC-1
cells, which migrated with HPTLC mobility between the standards GMl and GDla
similar to the migration ofGMlb. P815 fraction 6-8 also has the same ganglioside
results described above. Therefore, fractions were combined. P815 fractions 9 and 10
were identified by resorcinol-HCl reagent as impurities.
Gangliosides were isolated three times from the CTL cell line CTLL-2. This
laboratory tried to analyze the ganglioside extracts by HPTLC, but detection by
resorcinol-HCl reagent ofCTLL-2 gangliosides was not possible. Therefore was decided
to use the metabolic labeling approach, which proved a very sensitive method to detect
cellular gangliosides.
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Figure 3.18 HPTLC Chromatograph ofGangliosides from A20 and P815 Cell Lines.
G Std Frac 3-4 Frac 5-6 Frac 7-8 Frac 9
G std Frac 4-5 Frac 6-8 Frac 9 Frac 10
A20 (top) gangliosides elute in fractions 3-6; and P815 (bottom) gangliosides in fractions
4-8. The HPTLC plate was develop in CHCl3:CH30H: 0.25% CaCb (60:40:9, v/v/v) to
separate gangliosides. Gangliosides were visualized as purple bands on the HPTLC plate
with resorcinol-HCl reagent. The yellow spots are impurities or small amounts ofneutral
and sulfated glycosphingolipids.
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Figure 3.19 is the autoradiogram ofA20 (left) and P815 (right) cellular radiolabelled
gangliosides. The A20 gangliosides pattern (fraction 3-4) shows four bands, but actually
one is a doublet, after the densitometry analysis. The top band 12.8% could be GMl, the
doublet 63.3% could be GDla and the last band 18.9% could be GDlb. However,
metabolic radiolabelling also detects newly synthesized gangliosides; the doublet could
mean that some GD3 ganglioside is present. A20 fraction 5-8 has the same pattern just
described, but less intense. Nothing was detected in A20 fractions 9-15.
The P815 gangliosides pattern (right) is different from the A20 cells. Through
this approach three bands were identified in fraction 3-4. Apparently by this approach
the distribution of the gangliosides is very different in comparison to the HPTLC-
resorcinol-HCl results. Via densitometry three components were detected, as described
before for the P815 gangliosides, but this time the first one GMl is 12.6%, the unknown
is 7.9% and the third one GDla is 79.4%. The second one is a very small doublet,
indicating that could be GMlb. However, this laboratory cannot disprove that could be
the ganglioside GD3. P815 fraction 5-7 has the same pattern described above, but less
intense; fractions 8-13 were impurities. The differences in migration pattern in
comparison to figure 3.18 are not sufficiently clear.
As mentioned before YAC-1 cells contain a complex gangliosides composition in
comparison to A20 and P815 cells. By HPTLC resorcinol-HCl reagent detection method,
it was possible to identified around eight bands, with the possibility of their being eight
different gangliosides or less gangliosides, but migrating as doublets.
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The autoradiography analysis ofYAC-1 gangliosides corroborated our previous results
(Figure 3.20). The amount of gangliosides in YAC-1 cells plasma membrane is so large
in comparison to the other cell lines used in this experiment, that traces could be tracked
in fractions 9-11 and 12-15.
The main purpose of the metabolic labeling approach was to analyze gangliosides
isolated from the CTL cell line CTLL-2. Because, it was not possible to detected any
CTLL-2 gangliosides by HPTLC resorcinol-HCl reagent method.
Figure 3.21 shows the autoradiography ofCTLL-2 gangliosides. In CTLL-2 fraction 4-7
only two major bands were detected by densitometry analysis (86 and 11.3%). In
addition, in fraction 8-10 the bands were detected but less intense. Fractions 11-14 and
15-18 detected some impurities.
Purified gangliosides were isolated from four different cell lines. Therefore, we
decided to do a comparison between them. Figure 3.22 is the autoradiograph of the
murine gangliosides comparison. Unfortimately, the HPTLC plate apparently deactivated
and caused migration problems. Nonetheless, this laboratory can certify distinction that
the CTL-cell line CTLL-2 has much lower levels of gangliosides than the other murine
tumor target cells A20, P815, and YAC-1.
Figure 3.19 Autoradiograph ofA20 (Leftl and P815 (Right! Gangliosides.
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A20 and P815 cells were metabolically radiolabeled for 24 hr and washed. Radiolabeled
cellular gangliosides were isolated and analyzed by HPTLC (60:40:9, v/v/v) to separate
gangliosides. A20 lanes contained ~ 2,500 cpm and P815 lanes contained ~ 2,000 cpm
^H-labeled gangliosides. The plate was exposed to x-ray film for 2 weeks.
Figure 3.20 Autoradiograph ofYAC-1 Gangliosides.
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YAC-1 cells were metabolically radiolabeled for 24 hr and washed. Radiolabeled
cellular gangliosides were isolated and analyzed by HPTLC autoradiography. The
HPTLC plate was developed in CHCbiCHSOH: 0.25% CaCb (60:40:9, v/v/v) to separate
gangliosides. YAC-1 lanes contained ~ 9,500 cpm ^H-labeled gangliosides. The plate
was exposed to x-ray film for 2 weeks.
Figure 3.21 Autoradiograph of CTLL-2 Gangliosides.
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Frac. 15-18 Frac. 4-7 Frac. 11-14 Frac8-10
CTLL-2 cells were metabolically radiolabeled for 24 hr and washed. Radiolabeled
cellular gangliosides were isolated and analyzed by HPTLC autoradiography. The
HPTLC plate was developed in CHClsiCHSOH: 0.25% CaCU (60:40:9 v/v/v) to separate
gangliosides. CTLL-2 lanes contained ~ 5,600 cpm ^H-labeled gangliosides. The plate
was exposed to x-ray film for 2 weeks.
Figure 3.22 Autoradiograph ofMurine Gangliosides Comparison.
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Radiolabeled cellular gangliosides from each cell line were isolated and analyzed by
HPTLC autoradiography. The HPTLC plate was developed in CHClsiCHSOH: 0.25%




In examining the mechanism by which CTLs are resistant to lysis by their own
cytotoxic factor, i.e., perforin, this laboratory presented its data establishing that cells in
Gi are less susceptible to perforin-mediated lysis than those in S and G2 phases. Also,
this laboratory offered data indicating that when cells are arrested at the Gi/S interface of
the cell cycle, they are more susceptible to Fas-induce apoptosis. Enhanced susceptibility
to Fas-mediated apoptosis was also observed in serum-deprived cells. When treated with
CTL granules, A20 and P815 cells blocked with thymidine or aphidicolin were lysed less
efficiently than cycling controls. This imexpected result shows that Gi cells, and
especially those blocked at the Gi/S interface, are less sensitive to perforin-mediated
lysis. To confirm the influence of the cell cycle on susceptibility to perforin, this
laboratory also undertook experiments that did not depend on aphidicolin and thymidine.
Cells surviving exposure to perforin were isolated on density gradients and cell-cycle
profiles were compared to controls. The data showed enrichment for cells in Gi after
exposure to perforin, thus demonstrating an advantage for cells in this stage. It was also
observed that A20 and P815 tumor lines blocked with thymidine or aphidicolin were
much more sensitive to Fas-mediated apoptosis, as opposed to their decreased
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complementarities of the two pathways. Accordingly, a factor that reduces sensitivity of
target cells to perform renders them more susceptible to the alternate killing pathway of
CTLs. This recalls the complementarities ofCTLs and natural killer cells where by
tumor cells that escape immunosurveillence by downregulating or not expressing class I
MHC antigens and become more susceptible to NK cells, even as they are no longer
killed by CTLs.
CTLs lyse targets arrested in Gi/S essentially to the same extent they kill cycling
controls. This seems paradoxical in light of the observed decrease in susceptibility to
perforin and increase in sensitivity to Fas signals. Since blockade at Gj/S affects
sensitivity to the Fas and perforin pathways in opposite directions, Fas-mediated death
may be compensating for the perforin pathway, but this is far from clear. Alternatively,
intact CTLs must secrete concentrated and focused doses of perforin onto target
membranes, such as to overwhelm repair processes. This part of the study concludes that
the proliferative status may help the cells to be resistant to perforin, but this laboratory is
still searching for others factors that may induce resistance.
The resistance of cells in late Gi may also be pertinent to the resistance of CTLs
to their own secreted perforin. Because CTLs may not be proliferating while attacking
target cells, this process may protect them, in part, from secreted perforin. Then, the
proliferative status of CTLs during attack on targets may be important to their survival.
To address this hypothesis, first the resistance of the CTL cell line BIID-3 and the Gi
blocked cells to perforin and other pore forming molecules was studied to verify whether
the resistance phenomenon extends to other pore-forming molecules or is indeed unique
to perforin. The results indicated that A20 and P815 target cells at the Gi/S interface of
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the cell cycle are less susceptible to streptolysin-0 (SLO)-mediated lysis, but do not
differ in susceptibility to melittin. It was also observed that perforin-resistant CTL line
BIID-3 is resistant to SLO, but is readily lysed by melittin, like its tumor targets. These
data demonstrated specificity of resistance mechanisms in CTLs for large pore-formers
such as SLO but not to small membrane-perturbing polypeptides like melittin.
Small polypeptides like melittin can insert into the plasma membrane,
destabilizing its bilayer structure so rapidly that no opportunity is allowed for the cell to
recuperate from the attack, eventually killing the cell probably in a necrotic manner by
bursting or lysis. On the other hand, Gi/S and BIID-3 cells are less susceptible to
perforin and SLO, because as described in the introduction the cells can repair their
membrane by endocytosis. In contrast to melittin, perforin and SLO ^rst need to insert in
the plasma membrane then form a multimeric pore large enough to cause cell death by
apoptosis or necrosis due to membrane depolarization and osmotic lysis. This process is
relatively fast, but in comparison to melittin is much slower, giving time to cell to clear
the pore lesions by endocytosis and to recover from the attack.
To examine whether perforin resistance to CTLs is related to proliferative status
CTL-BIID-3 cell line at different points of the cell cycle were isolated by flow cytometry.
When treated with granules, BIID-3 at all stages of the cell cycle remains resistant to
perforin. This unexpected result confirmed that the resistance of CTLs to perforin is not
associated with its cell cycle status. The contribution of endocytic clearance of pore
lesions or a self-protection mechanism in the plasma membrane which inactivates or
inhibits perforin damage in CTLs needs to be clarified.
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In an effort to find out why Gi/S cells and CTLs are resistant to perforin and SLO
mediated lysis, endocytosis was monitored for uptake ofFITC conjugate dextran (FD-10)
by flow cytometry. P815 and A20 cells arrested at the Gi/S interface manifested
enhanced endocytosis, implying that endocytic clearance of lesions may explain the
decreased susceptibility of arrested Gi/S cells to pore-forming agents. Endocytosis was
also monitored for uptake of FD-10 in CTL-CTLL-2 cell line and the CD4 cell lines 5.5
and 5.9. All the T cell lines also manifested greater endocytosis in comparison to the
A20 control cell line. This implies that endocytic clearance of lesions may contribute to
the resistance of T cell line to perforin. But this result needs interpretation. Previous
studies have established [Verret, et al., 1987] that CD4 T cells are resistant to perforin
lysis and that cytolytic CD4 and all the CD8 lines used in the experiment were resistant to
granule mediated lysis. The notable difference was that CD4 T cells, but not CD8 cells,
succumbed when depleted of ATP. One of the explanations given in this report, for the
resistance of T cell lines, was that may be they are able to rapidly clear the pore lesions
by endocytosis. The other possibility mentioned is that T cell lines might have unusually
active ion pumps that restore intracellular ion concentrations, especially of Ca^^, and
prevent marked changes that result in the disruption of cell structures. These reports also
note that all these mechanisms must depend upon cellular ATP levels. CD8 T cells were
incubated with ATP depleting reagents (cyanide, azide and 2-deoxyglucose). The
exposure of target cells to ATP depleting reagents, enhanced the susceptibility of most
cells, including THl CD4 cells, to granule-mediated lysis, but left the CD8 CTLs
resistant. These results defined two modes of resistance to lysis: one ATP dependent, the
other ATP independent.
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The ATP dependent mechanism, which is very active in tumor targets and CD4 T
cell lines, may reflect the clearing of cell membranes’ perforin lesions through
endocytosis. The results from the endocytosis experiments are in agreement, and they
explain how Gi/S cells are less susceptible to granule-mediated lysis. They also suggest
that endocytic clearance may contribute to the resistance of CD4 T cells. CTLL-2 a
CD8-I- CTL line also manifested enhanced endocytosis in comparison to the A20 control.
It is also resistant to perforin in an ATP-independent manner. Thus, clearance ofperforin
pore lesions by endocytosis may contribute partially with the CTL resistance
phenomenon. However, other protection mechanism must contribute with the resistance
ofCTLs to granule-mediated lysis.
As mentioned earlier in the introduction, other mechanisms have been postulated
to explain the CTL resistance to perforin. Findings from many laboratories reviewed in
Liu, et al., 1995 suggest that a protein(s) present specifically on the surface of CTLs,
given the suggested name “protectin’’ could be responsible for the resistance of these
cells to granule-mediated lysis. Also, it has been suggested that the putative protectin
responsible for preventing aggregation of perforin in the CTLs membrane is probably
glycosylated. However, protectin has been neither isolated nor characterized. Although
enhanced endocytosis may contribute partially to the resistance of CTLs to perforin,
CTLs at all stages of the cell cycle remain resistant to perforin. Studies were begun to
explore whether composition of the plasma membrane, notably ganglioside content,
differ between perforin-resistant and sensitive cells.
Purified gangliosides were successfully isolated and detected by Resorcinol-HCl
method from YAC-1, A20 and P815 cell lines. Gangliosides from the CTLL-2 cell line
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were also successfully isolated, but the concentration of gangliosides in CTLL-2
membranes was less compared with membranes of tumor targets cell, since they could
not be detected by the Resorcinol-HCl method in the former. Therefore, to evaluate
ganglioside content in the CTLL-2 cell line, a metabolic labeling approach was used.
This method is more sensitive for detection of gangliosides. The radiolabeled purified
gangliosides of the cell lines CTLL-2, A20, P815, and YAC-1 were compared by HPTLC
autoradiography. Preliminary results showed that the CTL-cell line CTLL-2 has much
lower levels of gangliosides in comparison to the perforin-sensitive A20, P815, and
YAC-1 cell lines.
It is suspected that gangliosides may regulate various T cell effector functions.
Shedding of gangliosides from tumor cells may regulate immune response in cancer,
causing immunosuppression. Asialo-GMl is expressed in membranes ofNK cells, thus,
shed tumor gangliosides inhibitNK cytotoxicity.
Initial results show that the CTLL-2 cell line has lower amount of gangliosides in
their membranes than the tumor targets. Other studies have established that membrane
attributes, notably fluidity due to lipid content, modulate perforin pore formation. In an
effort to understand the CTL mechanism of self-protection to perforin, Rochel and
Cowan, in 1997, presented data on the influence of lipid headgroups on activity of the N-
terminal domain of perforin. They reported that pore formation is optimal in membranes
with lower phase transition temperatures. Incorporation and aggregation of the N-
terminal domain ofperforin in the membrane was suppressed in the gel state, suggesting,
that insertion and aggregation of perforin is easier in membranes withmore fluid lipids.
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The dependence of pore-forming activity and lipid composition may offer
important clues to the self-protection mechanism employed by CTLs against granule
mediated lysis.
In another studies, Antia, et al., (1992) showed by use of binding assays that the
packing of the phospholipids in the plasma membrane of CTLs is significantly tighter
(less fluid) than in target cells. This indicates that such a membrane is likely to prove
more refractory to pore formation than target cell membrane. Glycolipids compositions
also influence physical properties ofmembranes, for such reasons that it is worthwhile to
examine deeply the gangliosides composition in CTL cell lines and make a comparison
with CD4 T cells and tumor target cells.
Recent work has given rise to a fundamentally new way of thinking about
biological membranes. Now models are reemerging whereby lipids do not always mix
homogenously in membranes, but can be organized into microdomains in the bilayer.
Microdomain referred to as the lipid rafts are sphingolipid-rich domains. Raft
microdomains have been shown to play a key role in T cell activation. Tuosto, et al.,
(2001), showed that the process of T cell activation induced synthesis of GMl and
effector cells showed very high levels of this lipid. In this way, effector cells acquired
and improved signaling machinery by increasing the amoimt of rafts in their plasma
membrane. Also they stated, the fact that when compared with naive T cells, memory T
cells showed higher GMl levels, suggesting that raft lipid synthesis may be is regulated
during development and related to T cell responses.
Other studies reported by Martin, et al., (2001) are also in agreement in the
relationship between raft lipid synthesis or rearrangement and T cells responses. This
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group demonstrated that both the coreceptor CD28, which activates the T cells and the
cytotoxic T lymphocyte antigen 4 (CTLA-4) which is a negative regulator of T cell
activation, profoundly alter the surface expression of membrane rafts during T cell
activation.
Raft-like microdomains are detected at the synaptic interface between CTL and
targets. Thus, the surface of the CTL likely to encounter high concentrations of perforin
will be enriched in glycolipids. Therefore, if T cell activation is dependent in raft lipid
synthesis, then is possible when CTLs attack their targets, synthesis of raft lipids and
rearrangement is upregulated. The result is less fluid and tighter membrane, refractory to
perforin.
The data indicated presence of lipids in CTL membranes that are not found in
target membranes. These lipids may influence formation ofperforin lesion. These lipids
may also be important formation of raft-like domains. These observations suggest
important avenues for future study.
APPENDIX 1
Gangliosides, glycosphingolipids containing sialic acid, which are normally
present in plasmamembrane ofhigher eukaryotes; are extracted from tissues as mixtures
ofmany species that differ in their oligosaccharide or fatty acid composition.
Gangliosides were originally isolated in the brain; however they occur in every tissue
studied in different complexities. In addition to variation in molecular types, large
differences in total ganglioside concentration are seen for different tissues. Brain
contains the highest level; specifically the gray matter level greatly exceeds the
extraneural organs. Therefore, the gangliosides foimd on the cell plasmamembrane of
other organs and cell types, usually are minor components. In lymphoid cell cultures
lines the gangliosides concentration is lower and the small size ofavailable samples
usually present difficulties for their purification and analysis.
The isolation and purification of gangliosides from murine lymphoid cell cultures
lines presented a challenge. Many protocols were evaluated, a lot of research was done,
before the right one was identified. The methods used for detection and analysis, HPLC
and TLC, worked reasonably well. The problem was encountered during preparative
HPLC fractionation due to sample purification problems. These include drifting
background and appearance of ghost peaks. Another protocol was optimized for use with
cells in culture. Experiment established the importance of the desalting step.
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Therefore, in the next stage after the DIPE/1-Butanol, partitioning step in the
gangliosides isolation, a Sephadex G-50 gel filtration step was added for desalting
purposes. Resulting thin layer chromatograms were cleared. However, the gangliosides
samples had impiuities which affected their migration pattern in the TLC. A protocol -
optimized by Glyco Tech Company was selected. This procedure is amodification of the
method first described by Ladisch and Gillard; 1985 and 1987. The procedure is





Method ofSvennerholm and Fredman: BBA 617, 97,1980.
• This procedure, which was optimized for quantitative extraction of gangliosides, uses
a chloroform-methanol-aqueous ratio of4:8:3 (v/v).
• The order ofaddition is important to ensure maximal precipitation (removal) of
hydrophobic proteins.
• To the tissue or cell sample add 3 ml of ice-cold distilled water and homogenize at
4°C.
• Add the homogenate to 10.6 ml of rapidly stirring methanol at room temperature.
• Finally, add 5.3 ml of chloroform to the stirring suspension.
• The solids are removed by centrifugation. The supernatant is removed and kept in a
separate tube. Then the precipitate is reextracted with chloroform-methanol-water
(C:M:W) (4:8:3, v/v), and the supernatants combined for further processing.
• Next the supernatant (lipid extract) is dried completely using a speed vacuum
concentrator.
• After drying the samples are resuspended in an small volume ofC:M (1:1) and
centrifuge to remove any insoluble material.
• Next the final clear, total lipid extract is dried again.
• Then resuspend in (C:M:W) 4:8:3 to start the partitioning step.
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Partition B: Chloroform-Methanol-Water
Method ofSvennerholm and Fredman; BBA 617, 97; 1980.
This method follows directly from extraction B, above.
• The total volume of the extracts in chloroform-methanol-water (4:8:3, v/v) are
measured, and 0.173-fold of that voliune in water is added, for a final C:M:W ratio of
4:8:5.6 (v/v).
• The extract is mix and the two phases allowed to separate (centrifugation to
accelerate this step is practical).
• The hydrophilic upper phase is removed, and constitutes ~ 80% of the volume. The
hydrophobic lower phase is reextracted with theorical upper phase made with 10 mM
aqueous KCl instead ofwater.
• This method was designed to maximize partitioning of gangliosides into the upper
phase, and only minor amounts of gangliosides (including some of the GM4 and
GM3) partition into the lower phase.
• The ganglioside-containing aqueous phase is evaporated to dryness in a Speed
Vacuum concentrator.
• Then 2 ml ofwater-methanol (1:1) are added to the residue and to bring it into
solution sonication is recommended.
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Thin Laver Chromatography (TLO
Stationary phase: High Performance TLC plates- LHP-K preadsorbent silica gel 60
Glass support plates (layer thickness of200 pm) from Whatman.
Mobile phase (solvent system): Chloroform: methanol: 0.25% CaCla aqueous (60:35:8)
Detection: Resorcinol-HCl Reagent
Sensitivity: Medium-high sensitivity -nmol-high pmolar
Note: If scanning densitometry is used then sensitivity is between 10-25 pmolar.
Results: Blue-Purple bands were detected in the standards and in some gangliosides
samples. However the gangliosides samples were migrating faster in comparison to the
standards. Also the gangliosides samples did not migrated in straight line like the
standards, a curve was observed in the chromatogram, an indication of impurities within
the sample.
Figure A.l TLC Chromatogram ofCTLL-2 Ganeliosides Extracts.
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Gan. Std. GMl CTLL-2 Blank
Total cellular gangliosides were isolated and purified fi'om CTLL-2 tumor cells. The
HPTLC plate was develop in CHClsiCHSOH: 0.25% CaCb (60:35:8, v/v/v) to separate
gangliosides. Gangliosides were visualized as purple bands on the HPTLC plate with
resorcinol-HCl reagent.
Figure A.2 TLC Chromatogram ofP815 Gangliosides Extracts #1
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GMl Frac3-4(10ul) Frac.3-4 (30ul) Frac.3-4 (60ul)
Total cellular gangliosides were isolated and purified from P815 tumor cells. The
HPTLC plate was develop in CHCbiCHSOH; 0.25% CaCb (60:35:8, v/v/v) to separate
gangliosides. Gangliosides were visualized as purple bands on the HPTLC plate with
resorcinol-HCl reagent.
Figure A.3 TLC Chromatogram ofP815 Gangliosides Extracts #2
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GMl Blank Frac.3-4
Total cellular gangliosides were isolated and purified from P815 tumor cells. The
HPTLC plate was develop in CHCl3:CH30H: 0.25% CaC^ (60:35:8, v/v/v) to separate
gangliosides. Gangliosides were visualized as purple bands on the HPTLC plate with
resorcinol-HCl reagent.
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Microbore High Performance Liquid Chromatography (HPLC)
Column: Waters Spherisorb- Amino (NH2), 5uM particle size (250 mm x 2.1 mm)
Guard Column: Waters Spherisorb- Amino (NHi), 5uM particle size (1 mm x 20 mm)
Sensitivity: Highly sensitive in pmolar range
Solvent System: Solvent A: Acetonitrile- 5 mM Phosphate Buffer, pH 5.6 (83:17)
Solvent B: Acetonitrile-20 mM Phosphate Buffer, pH 5.6 (1:1)
Note: 5mM and 20 mM Phosphate Buffers should be stored at 4°C when not in used.
• The separation was performed with programmed gradient elution starting with
solvent A for 6.4 minutes, followed by a linear gradient to 77% solvent A,
23% solvent B for 37.6 minutes. Finally by a linear gradient to 100% solvent
B for 40 minutes.
• The flow rate was 88 pl/minute and the temperature 25®C. The elution was
monitored by a UV detector at 197 nm. The separation was completed within
90 minutes. For regeneration of the column, it was washed for 20 minutes
with solvent B and re-equilibrated for 20 minutes with solvent A.
• Gangliosides are supposed to be separated according to their sialic acid
content. This separation effect is presumably caused by the weak anionic
exchange properties of the NHi-phase in the presence of the phosphate buffer.
• Also when the sample is free of impurities, an efficient separation of
gangliosides differing in carbohydrate composition but bearing equal numbers
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Results; When the HPLC system was finally equilibrate it was kept it out of bacterial
contamination due to the phosphate buffer. Clear; the ganglioside samples had a lot of
low molecular weight impurities, which were interfering with the gangliosides migration.
In addition, it was detected that the “standards” had impurities as well, confirming the
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